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ALT: Alternative Lengthening of Telomeres  
APB: ALT associated PML body  
APL: Acute Promyelocytic Leukemia  
ATM: Ataxia Telangiectasia Mutated 
ATR: Ataxia Telangiectasia and Rad3 related  
BLM :Bloom’s syndrome protein  
BSA: Bovine serum albumine  
CBP: CREB-binding protein 
CDKs: Cyclin-Dependent Kinases  
ChK: Checkpoint Kinase  
CK2: Casein Kinase-2  
CMV: Cyto Megalo Virus 
DAPI: 4',6-diamidino-2-phenylindole  
DBMA: 7,12-dimethylbenzanthracene  
DC: Dyskeratosis congenital  
DDR: DNA damage response  
DMEM: Dulbecco’s Modified Eagle Medium  
DNA-PK: DNA dependent Protein Kinase  
DNA-Pkcs: DNA dependent Protein Kinase catalytic subunity  
DNMT: DNA methyltransferase 
DSB: DNA Double Strand Break  
ECTR: Extra-Chromosomal Telomeric Repeats  
ERCC1: Excision Repair Cross-Complementing 1  
ERK: Extracellular signal-Regulated Kinase  
FBS: Fetal Bovine Serum  
FISH: Fluorescence In Situ Hybridization  
G4: G-quadruplex  
HDAC: Histone Deacetylases  
HP1: Heterochromatin Protein 1  
HR: Homologous Recombination  
KO: Knock Out  
MEFs: Mouse Embryonic Fibroblasts 
MRE11 mRNA Meiotic Recombination 11 messenger RNA  
MRN complex: Mre11-RAD50-NBS1 complex 
NB: Nuclear Body 
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NBS1: Nijmegen Breakage Syndrome 1 
NHEJ: Non-Homologous End Joining 
NLS : Nuclear Localization Signal 
ORC: Origin Recognition Complex  
PARP : Poly-ADP Ribose Polymerase 
PIKK : Phosphatidil Inositol 3- Kinase-like Kinase 
PML : Promyelocytic Leukaemia protein 
PML NBs: PML Nuclear Bodies  
PNA: Peptide Nucleic Acid  
POT1: Protection Of Telomeres 1  
RA: Retinoic Acid  
RAP1: Repressor/Activator Protein 1  
RAR: Retinoic Acid Receptor  
RB: Retinoblastoma protein  
RBCC: RING finger, B boxes, Coiled-coil  
RHPS4: 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl] 
acridinium methosulfate  
RNP: RiboNucleoProtein  
RPA: Replication Protein A  
RT: Reverse Transcriptase  
SAHFs: Senescence Associated Heterochromatin Foci  
SCID mice: Severe Combined Immunodeficient mice  
shRNA: short hairpin RNA  
SMC: Structural Maintenance of Chromosomes  
SUMO: Small Ubiquitin-like Modifier  
TEBP: Telomere End Binding Protein 
TER: Telomerase RNA subunity 
Terc: Telomerase RNA Component  
TERT: Telomerase Reverse Transcriptase  
TIFs: Telomere Dysfunction- Induced Foci  
TIN2: TRF1-Interacting Nuclear factor 1  
TPA: 12-O-tetradecanoylphorbol-13-acetate  
TPE: Telomere Position Effect  
TPP1: (PIP1/PTOP/TINT1)  
TRF: Telomere Repeat binding Factors  
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WRN: Werner’s syndrome protein  
WT: Wild Type  
XPF:RNA-Polymerase σ Factor 
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Telomeres are specialized structures that cap chromosomes ends, 
protecting them from degradation and processing by the DNA-
repair machinery. In normal cells, telomeres  become progressively 
shorter during replication, and this leads to replicative senescence. 
The majority of human tumors (approximately 90%) express the 
ribonucleic complex telomerase, that prevents this continuous 
DNA loss, thus endowing cells with immortal growth properties. In 
the remaining 10% of tumors telomerase is not expressed, and 
telomeric DNA is preserved through alternative mechanisms 
 (Alternative Lengthening of Telomeres, ALT). An hallmark of all 
ALT tumor cell lines is the presence of nuclear structures that 
localize exclusively at telomeres (ALT-associated PML nuclear 
bodies, APBs). Here we show that PML (ProMyelocitic Leukemia 
protein), a nuclear protein that is an essential component of PML 
nuclear bodies (PML-NBs), colocalizes with telomeres not only in 
telomerase-positive tumor cell lines, but also in normal cells, 
although at few telomeres. Interestingly, in normal cells telomere-
specific DNA-damage induced recruitment of PML to damaged 
telomeres. Furthermore, PML depletion led to the formation of 
Telomere Dysfunction-Induced Foci (TIFs) and consequent growth 
inhibition in normal and ALT cell lines.  Preliminary cytogenetic 
characterization of PML-depleted fibroblasts revealed diffused 
genomic defects, suggesting that PML is a key regulator of 
telomere maintenance and whole genomic stability. Unpublished 
data from our lab have shown that  DNA-PKcs, an enzyme 
involved in DNA repair and telomere stability, is part of the PML-
macromolecular protein complex. To investigate the mechanism 
involvement of PML activity in telomere maintenance we studied 
by confocal microscopy its interaction with the active 
phosporylated form of DNA-PKcs in ALT cell lines and in normal 
cells. As expected, not only the two proteins interacted at 
telomeres, but PML was essential for the correct localization of 
DNA-PKcs at the chromosome ends. Additionally, telomeric-
specific damage in normal cells increased the interaction between 
DNA-PKcs and PML. Altogether these findings shed light on a 
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novel role for PML in the regulation of telomere metabolism, and 
are the basis for future investigations on its role in both aging and 
cancer. 
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1. Telomeres 
 
 
The evolution of linear genomes required the development of 
mechanisms that could protect the chromosome ends from 
genomic instability and DNA loss.  Chromosomes ends, in fact, are 
subjected to enzymatic attacks by the systems that cells developed 
to detect and repair DNA breaks.  To this end, specialized 
structures named telomeres (from the Greek word ‘end part’) have 
evolved at the chromosome ends of linear genomes  to cap and 
protect these regions.  
Moreover, when scientists began to understand the mechanism 
of DNA replication, they predicted that the lagging strand of linear 
chromosomes copied by the semi-conservative replication 
machinery could not be fully replicated.  As it turned out, this can 
be explained by what James Watson in 1972 named the "end 
replication problem" (Watson, 1972). The DNA polymerase works 
in a 5’ to 3’ direction and replicates the leading strand completely. 
On the contrary, the lagging strand is replicated in short fragments, 
called Okazaki fragments, by using RNA primers as templates. 
These RNA primers are then converted to DNA, with the exception 
of the last RNA primer, at the 5' end of the lagging strand. Thus, a 
section of DNA is lost during each cycle of replication. The extent 
of this loss is estimated to be around 50-150 bp (Makarov et al., 
1997) of DNA at each round of cell cycle. In 1973, A.M. 
Olovnikov postulated the existence of ‘telogenes’, sequences of 
DNA that carry no genetic information located at the ends of the 
DNA molecules, that would shorten during each mitotic arrest 
cycle until they reached a critical level, that resulted in the arrest of 
cell division (Olovnikov, 1973). Subsequently, Elizabeth 
Blackburn discovered in Tetrahymena that telomeres consist of a 
simple repeated DNA sequence (Blackburn and Gall, 1978), and, 
together with Jack Szostak, was able to demonstrate that these 
telomeric repeats protect the chromosomes from degradation 
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(Szostak and Blackburn, 1982). For this discovery they received 
the 2009 Nobel Prize in Physiology or Medicine.  
Telomere erosion is considered to be a mitotic clock, as it 
regulates the number of divisions that a given cell can undergo 
before entering a senescent state (Smith and Whitney, 1980). 
 
 
1.1. Telomere Structure 
 
 
1.1.1 The telomere sequence. 
 
Telomeres consist of G-rich DNA repeats (irregular TGGG 
repeats in yeast, regular TTAGGG repeats in vertebrates) capped 
by complexes of specialized proteins (de Lange et al., 1990).  
The length of these telomeres varies amongst different 
organisms and even in the same organisms between cells with 
different origin. For example, yeast telomeres are about 300 bp 
long, whereas in human cells the telomere length spans between 3 
and 20 kb, mice have long telomeres that can reach up to 150 kb 
(Moyzis et al., 1988).  
Telomeres in vertebrates end in a 3’ overhang of the G-rich 
strand (G-strand overhang) (Wright et al., 1997), that spans 
between 50 and 400 nt and can fold back and invade the double-
stranded region of the telomere, generating a looped structure 
known as the telomere loop or T-loop (Griffith et al., 1999) (Fig.1) 
that protects chromosome ends. It still has to be demonstrated 
whether T-loops are present at all chromosome ends, whether their 
function regards solely chromosome protection, or whether they 
have a role in regulating other features of telomeres, like the 
recruitment of the telomere-specific reverse transcriptase enzyme, 
known as telomerase (see following paragraphs). T-loops have 
been found at telomeres of humans, mice, trypanosomes and 
plants. The 3’ G-rich overhang can also fold into a 4-stranded 
DNA structure, termed G-quadruplex (G4) (Williamson, 1994). G4 
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formation has been shown to inhibit telomere elongation in vitro, 
by inhibiting the activity of the  telomerase enzyme (Han and 
Hurley, 2000). 
 
 
Figure 1. The T-loop structure. The 3’ overhang is strand-invaded into the adjacent duplex 
telomeric repeat array, forming a T-loop. (de Lange 2005)  
 
Adjacent to the human terminal (TTAGGG)n repeat is a 
complex region of segmentally duplicated DNA tracts, generally 
referred to as subtelomeric DNA repeats. This class of low-copy 
DNA  repeats is characterized by very high sequence similarity 
(90% to 99.5%) between duplicated tracts, and very large and 
heterogeneous duplicated segments (1 kb to > 200 kb). Some of the 
segmental duplications are unique to subtelomeric repeat regions, 
some are shared with a subset of pericentromeric repeat regions, 
and some are shared with one or several interstitial chromosomal 
loci. 
 
 
 
1.1.2. The shelterin complex. 
 
 
Telomeric repeat sequences are recognized by a specific set of 
sequence-and structure-specific DNA-binding factors.  
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For example, the shelterin complex, composed of six proteins, is 
considered to be strictly telomere specific and necessary to protect 
human telomeres (de Lange, 2005): the shelterin components, in 
fact,  are specific for telomere DNA, they localize at chromosome 
ends and are expressed throughout the cell cycle.  
Two shelterin subunits, the Telomere Repeat binding Factors 
TRF1 and TRF2, bind with high specificity the double-stranded 
TTAGGG repeats of the telomere, with their SANT/Myb-type 
DNA-binding domain (Court et al., 2005) (Fig.2). These proteins 
form homodimers and higher order oligomers. TRF1 can bind 
neighbouring telomeric sequences, but can also bridge two 
different DNA molecules or distant regions of the same telomere 
(Griffith et al., 1998). The amount of TRF1 in telomeres can be 
linked to the telomere length and this protein is considered the 
main regulator of telomere length (Smogorzewska et al., 2000). 
Accordingly, a dominant negative mutant of TRF1 causes telomere 
elongation in telomerase-positive cells, while TRF1 overexpression 
causes gradual shortening of telomeres (Karlseder et al., 2003).  
Structural differences between TRF1 and TRF2 are responsible 
for their different functions. While TRF1 is mainly involved in 
telomere length control, TRF2 is involved in telomere protection 
(Blasco, 2005a; van Steensel et al., 1998). In particular, TRF2 
stabilizes the G-strand overhang and promotes telomere looping 
(Stansel et al., 2001). Inhibition of TRF2 function results in 
telomere fusions, as consequence of the covalent bond between  G-
strands of different chromosomes and is dependent on non-
homologous end-joining (NHEJ)(Smogorzewska et al., 2002) 
TRF2 also localizes at double-stranded breaks of non-telomeric 
DNA, suggesting a more general role for this protein in DNA 
damage response (Bradshaw et al., 2005).  
A third shelterin protein, POT1 (Protection Of Telomeres 1), 
directly recognizes TTAGGG repeats, but specifically binds to 
single-stranded telomere overhangs (Lei et al., 2004) (Fig.2). 
POT1 is considered a chromosome end-capping protein. Becuase 
POT1 localizes just two nucleotide from the end of the duplex 
Cristiano Marinelli 
Pag 20  
telomeric DNA in the 3’ overhang, it is reasonable to assume that 
this protein may protect the 5’ end of telomeric DNA. Loss of the 
G-overhang causes a reduction in the binding of POT1, and leads 
to aberrant regulation of telomere length. Depending on its 
localization on the single-stranded overhang, POT1 can either 
facilitate or inhibit the telomerase activity (Lei et al., 2005). POT1 
deficiency causes the activation of a DNA damage checkpoint  and 
deregulated episodes of homologous recombination at the telomere 
(Wu et al., 2006).  
TRF1, TRF2 and POT1 are interconnected by three additional 
shelterin proteins, TIN2, TPP1 and RAP1 (Fig.2). TIN2 (TRF1-
Interacting Nuclear factor 2) provides a scaffold for the binding of 
other telomeric proteins. TIN2 is though to recruit TRF1 and TRF2 
and stabilize TRF2 on telomeres. TIN2 also interacts  with TPP1 
(PIP1/PTOP/TINT1) that links the TRF1-TIN2-TRF2 complex 
with 
POT1 (Liu et al., 2004; Ye et al., 2004). These functions make 
TIN2 a key regulator in keeping telomeric proteins together, and, 
because of its function in mediating the TRF1 complex, they 
identify it as negative regulator of telomere length. 
 
Figure 2. The shelterin complex. TRF1 and TRF2 bind the double-stranded repeats of the telomere. 
POT1 binds to single-stranded telomere overhang. TIN2, TPP1 and RAP1 are scaffold proteins that 
interconnect TRF1, TRF2 and POT1. (de Lange 2005) 
 
TPP1 recruits POT1 to the TIN2/TRF1 complex. Its structure 
reveals two protein-protein interacting domains, a central region 
that has affinity for POT1, and a C-terminus for the binding to 
Dottorato di ricerca in Genetica e Biologia Molecolare 
 Pag. 21  
TIN2. TPP1 acts as a negative regulator of telomere length, and its 
depletion causes telomere elongation (Ye and de Lange, 2004).  
Rap1 (Repressor/Activator Protein) is a telomere specific 
protein that acts as negative regulator of telomere length. Rap1 is 
connected to the telomere complex through protein-protein 
interaction with TRF2 (Li and de Lange, 2003; O'Connor et al., 
2004). Rap1 has been isolated in a complex with TRF2 and other 
proteins involved in homologous and in non-homologous 
recombination (RAD50, MRE11, Ku70/86 and PARP)(O'Connor 
et al., 2004). 
 
 
1.1.3. Other telomeric proteins. 
 
In addition to shelterin, other factors interact dynamically with 
mammalian telomeres and influence the stability of chromosome 
ends. Many of these proteins are involved in DNA recombination 
and repair. The DNA repair factors associated with telomeres are 
members of the MRN complex [namely MRE11 (Meiotic 
Recombination 11), RAD50 and NBS1], involved in DNA double-
strand breaks repair, DNA-PK (DNA dependent Protein Kinase, 
that comprises a catalytic subunit DNA-PKcs and the regulatory 
subunits Ku70 and Ku80), ATM (Ataxia-Telangiectasia Mutated) 
and ATR (ATM and Rad3-related). DNA processing enzymes at 
telomeres are the RecQ-like helicases WRN (Werner’s syndrome 
protein) and BLM (Bloom’s syndrome protein), ERCC1/XPF 
(Excision Repair Cross-Complementing 1/ RNA-Polymerase σ 
Factor) and the 5’ exonuclease Apollo. Tankyrase 1 and 2 and 
PARP (Poly ADP-Ribose Polymerase) also associate with 
telomeres (de Lange, 2005; Verdun and Karlseder, 2007)(Fig.3). 
Proteins that are part of the shelterin complex like TRF1, TRF2 
and POT1, regulate the access and the activity of the different 
enzymes mentioned above. For example, TRF2 and POT1 
modulate the recruitment of WRN and BLM, required for an 
efficient telomere replication. TRF2 can sequester ERCC1/XPF in 
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an inactive form, and following  TRF2 inhibition, these enzymes 
are involved in the removal of the G-tail (Zhu et al., 2003). 
 
 
 
Figure 3. The mammalian telomeric complex. Specific protein complexes bind to the double- and 
single- stranded telomeric DNA. The component of the shelterin complex are shown in bold text. 
Other factors that can interact with telomeres are listened. Bidirectional arrows indicate interactions. 
(Verdun and Karlseder 2007) 
 
 
1.2. Replication of telomeres. 
 
A major question in telomere biology regards their replication, 
especially concerning their replication origins. In yeast, the origin 
of replication is not within the telomeric repeats, but in 
subtelomeric regions (Wellinger et al., 1993). In mammals, 
although their sequence is not encoding for any protein, we cannot 
exclude the possibility that telomeres can be used as replication 
origins. In particular, TRF2 could contribute to the formation of 
origins within telomeres, because of its extra-telomeric role in the 
initiation at the oriP origin of the Epstein-Barr DNA virus (Deng et 
al., 2002). Recent findings report the possibility of a direct 
recruitment of the Origin Recognition Complex (ORC) by TRF2 
and subsequent TRF2-mediated opening of the double helix 
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(Amiard et al., 2007). In yeast, the replication of telomeres occurs 
in late S phase; conversely, Verdun and Karlseder have shown that 
mammalian telomeres replicate in two moments during cell cycle: 
in S phase and in G2-M phase (Verdun and Karlseder, 2006). It has 
been postulated that the late replication of the telomeric regions 
might have a role in coordinating cell-cycle events. Replication of 
telomeres is a complex process, due to the G-rich and repetitive 
nature of telomeric DNA; this property of telomeres, in fact, allows 
for the formation of secondary structures, such as G-quadruplexes 
and T-loops or other structures that have only been observed in 
vitro (triple helices, four-way junctions and D-loops). These 
structures hinder the progression of the replication fork, which 
consequently stops or stalls at telomeres. When this happens, the 
cell activates an ATM/ATR-dependent DNA-damage response, 
mediated by the MRE11-RAD50-NBS1 complex, which is 
involved in the initial recognition of double-strand DNA breaks. 
The single-stranded DNA-binding protein RPA (Replication 
Protein A) also appears at telomeres in S phase (Verdun and 
Karlseder, 2006). This and other telomeric proteins are 
fundamental for an efficient telomere synthesis, because they 
mediate the recruitment of helicases and possibly other co-factors 
that are capable of removing or remodelling the telomeric 
structures that can impair fork progression. Accordingly, in fission 
yeast, the homologues of TRF1 and TRF2, Taz1 are crucial for the 
efficient replication of telomeres . In human cells, the RecQ-like 
helicases WRN and BLM are important during replication of 
telomeres. WRN localizes to telomeres in S phase and is involved 
in removing the secondary structures that can be formed in the G-
rich strand (Crabbe et al., 2004). The fine recruitment of WRN and 
BLM is performed by TRF2 and POT1. When the fork approaches 
the T-loop, there is an accumulation of superhelical stress that 
counteracts the action of topoisomerases. In this scenario, the 
binding of TRF2 to positive supercoils is energetically favoured, so 
that this protein is enriched around the fork and acts as a 
topological stress sensor (Amiard et al., 2007). The high 
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concentration of TRF2 favours the opening of the T-loop by 
activating the RecQ-helicases. TRF2 can therefore promote the T-
loop formation or resolution, depending on the different 
subcomplexes in which it takes part during the cell cycle.  
After telomere replication, the telomere overhangs are 
generated. For the leading telomere, the product of the replication 
is either blunt or 5’ protruding, which implies the existence of a 5’ 
resection activity to convert it into a 3’ overhang. On the contrary, 
the newly generated lagging-strand carries a short 3’ overhang, 
resulting from the removal of the most distal RNA primer used for 
the synthesis of Okazaki fragments. It is not clear whether this 
primer is placed at the very end of the chromosome or a few bases 
from the end, allowing a longer overhang than the length of the 
RNA fragment (Fig.4).  
 
 
 
Figure 4. End replication and processing. Semi-conservative replication of telomeres generates a 
blunt- ended leading-strand product and a lagging-strand product with a short overhang. Nucleolytic 
digestion in the 5’ to 3’ direction then generates G overhang. 
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Whether a 5’ resection activity also processes the lagging 
telomere is still unknown. Currently, no candidates for overhang-
generating nucleases have been identified, but the 5’ resection 
activity seems to involve the MRE11-RAD50-NBS1 complex. In 
Mre11-defective yeast strains, in fact, the length of the G-tail is 
reduced (Larrivee et al., 2004). However, G-tails are still present in 
cells that express nuclease-dead alleles of Mre11, suggesting that 
the nuclease activities of MRE11 are not strictly necessary for 
telomeric 5’ resection. 
 
 
1.3. Telomere elongation and Telomerase. 
 
 
Telomeric DNA inexorably shortens during replication until it 
reaches a critical length, thus triggering cell cycle arrest and onset 
of senescence. As exception to this mechansism, germ cells, some 
populations of stem cells and cancer cells, activate compensating 
mechanisms to preserve genome integrity and telomere functions 
and continue to divide. These mechanisms can involve 
recombination events, but they are more commonly based on the 
extension of the 3’ ends by telomerase. Telomerases are 
specialized reverse transcriptase (RT) complexes that catalyze the 
de novo extension reaction at the absolute ends of chromosomes. 
Active telomerases have been detected in extracts of human cells 
in early embryogenesis, in the germline, in a subset of epithelial 
and lymphoid progenitors and in almost all types of cancer (Collins 
and Mitchell, 2002; Forsyth et al., 2002). Inactivation of 
telomerases in human somatic cells has been proposed to be 
required for quiescence, differentiation and cell death and it is 
supposed to be a tumour-suppressor mechanism (Sharpless and 
DePinho, 2004; Shay and Wright, 2005; Wong and Collins, 2003).  
The catalytic function of telomerases requires the activity of a 
RNA subunit, called TER, and the protein telomerase reverse 
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transcriptase, TERT. In fact, TER contains aninternal RNA 
molecule that is used as a template for the synthesis of telomeric 
repeats (Yu et al., 1990). The human TER primary transcript is 
synthesized by RNA polymerase II, and assembled to form a RNA 
motif (H/ACA motif), which contains conserved sequences and 
hairpins. H/ACA proteins assemble with this motif, to generate a 
stable ribonucleoprotein (RNP) (Mitchell et al., 1999) (Fig.5). 
 
 
Figure 5. Telomerase holoenzyme. Ribonucleoprotein (RNP) consists of TER transcript assembled 
with H/ACA proteins, and contains a RNA molecule that can be used as a template. TERT binds the 
RNP to form the holoenzyme. (Collins 2006) 
 
TERT harbours a central region that shares homology with the 
active-site motifs of the viral RT enzymes. TERT binds the RNP to 
form the telomerase holoenzyme (Fig.5). Additional holoenzyme 
proteins are required to endow the enzyme with the ability to 
function on chromosome substrates. TERT, TER and single-
stranded DNA form a network of protein-nucleic acid interactions 
that orchestrate the proper positioning of the template and primer 
in the active site. After the addition of several repeated DNA 
sequences, the last event of the ‘telomerase cycle’ is the 
dissociation of the telomerase-RNA-telomeric-DNA hybrid 
(Collins, 2006) (Fig.6).  
The interaction between telomerase and telomeres is a finely 
regulated mechanism, that ensures that telomerases acts on short 
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telomeres, but not on those that do not require telomere elongation, 
thus maintaining the telomere at an appropriate length. The 
accessibility of the G-overhang to telomerase is probably not 
dependent solely on the length of the telomere itself, but also on 
the phase of the cell cycle (Shore and Bianchi, 2009). The 
replication reaction opens the telomere to enzymes and proteins 
that generate a structure that allows for telomerase-mediated 
elongation. In budding yeast, telomerase activity is restricted to the 
S phase and is triggered by DNA replication (Marcand et al., 
2000). 
 
 
 
Figure 6. Telomerase extends the length of a telomere. Telomerase is an enzyme that lengthens 
telomeres by adding on repeating sequences of DNA. Telomerase binds to the ends of the telomere 
via an RNA template that is used for the attachment of a new strand of DNA. Telomerase add 
several repeated DNA sequences then releases and a second enzyme, DNA Polymerase, attaches the 
complementary strand of DNA completing the double stranded extension of the chromosome ends. 
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As for elongation of short telomers in several systems, the 
existence of a mechanism that senses the length of telomeric DNA 
and reduces the telomerase-dependent extension when telomeres 
exceed a certain length has been proposed. In human cells this 
negative feedback mechanism involves TRF1, which controls 
telomere length by inhibiting the activity of telomerases at 
individual telomeres (van Steensel and de Lange, 1997). 
Accordingly, overexpression of TRF1 leads to telomere shortening, 
whereas expression of a dominant-negative allele leads to telomere 
elongation. The T-loop structures also block telomerase access and 
the shelterin complexes control telomere length by regulating the 
transition from a closed to an opened T-loop conformation. 
 
 
1.4. Alternative Lengthening of Telomeres mechanisms 
(ALT).  
 
 
Although telomerase activity appears to be the most prevalent 
mechanism used by tumours to circumvent the telomere length-
dependent barrier to proliferation, this enzyme is not activated in a 
subset of tumours and in some tumour-derived cell lines or in vitro 
immortalized cell lines (Bryan et al., 1995; Reddel et al., 1997). To 
prevent telomere shortening, however, these cells adopt a 
mechanism termed Alternative Lengthening of Telomeres (ALT), 
which relies on recombination (Henson et al., 2002).  
Evidence for ALT activity has also been found in the tissues of 
late generation telomerase-null mice (Herrera et al., 2000). The 
ALT mechanism has precise features. A characteristic of ALT cells 
is the high heterogeneity of their telomere length, with repeats 
ranging in size from >20Kb to <5Kb. Visualization of telomeres by 
fluorescence in situ hybridization (FISH) shows that the 
heterogeneity in telomere length in ALT cell populations can be 
explained by the heterogeneity that exists within individual cells. 
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In fact, whereas some chromosome ends have no detectable 
telomeric sequence while others have very long telomere signals 
(Perrem et al., 2001). Another peculiar feature of ALT cells is the 
presence of ALT-associated PML bodies (APBs) (Yeager et al., 
1999). PML (Promyelocytic Leukaemia Protein) is involved in 
many biological functions, and aggregates with other proteins in 
nuclear structures called PML nuclear bodies (PML NBs) (see 
introduction). APBs are PML NBs with ALT-specific contents. In 
addition to constitutive components of PML NBs, they also contain 
telomeric DNA, telomeric binding proteins (TRF1 and TRF2) and 
proteins involved in DNA recombination, replication and repair. 
These proteins include RAD51, RAD52 and RPA (Yeager et al., 
1999), RAD51D (Tarsounas et al., 2004), BLM (Yankiwski et al., 
2000), WRN (Johnson et al., 2001), Rap1 and BRCA1 (Wu et al., 
2003), MRE11, RAD50 and NBS1 (Wu et al., 2000), ERCC1 and 
XPF (Zhu et al., 2003), hRAD1, hRAD9, hRAD17 and hHUS1 
(Nabetani et al., 2004), Rif1 (Silverman et al., 2004) and hnRNP 
A2 (Moran-Jones et al., 2005). APBs appear as disc or ring shaped 
structures and they binding proteins that they contain is often 
greater than the amount present at individual telomeres. APBs 
were often detected by visualizing TRF1 or TRF2 within a PML 
NB (Fig.7), and the signal of TRF1 or TRF2 is larger and brighter 
than the signals from individual telomeres. They are present in 
only about 5% of interphase cells (Yeager et al., 1999) but the 
percentage increase consistently in late G(2)/M phase of the cell 
cycle (Grobelny et al., 2000). 
The proportion of APB-positive cells in a given population can 
be increased from <5 to >50% by restriction of methionine (Jiang 
et al., 2007), an essential amino acid. Methionine restriction, in 
fact, causes cell-cycle arrest in G0/G1 phase. Methionine has a role 
as a methyl donor for methylation of DNA, RNA and proteins, so 
methionine restriction could reduce the levels of methylation at 
telomeric and subtelomeric regions, creating a favourable 
environment for the assembly of APBs. 
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Figure 7. ALT-associated PML bodies (APBs). ALT cells contain a novel form of PML body in 
which PML co-localizes with telomeric DNA and telomeric binding proteins. Indirect 
immunofluorescence in U2OS ALT cells shows the co-localization of TRF1 (red) with PML protein 
(green) in large subnuclear structures. 
 
Under these conditions, RNA interference of proteins of APBs 
has helped in establishing that PML, Sp100, TRF1, TRF2, TIN2, 
Rap1, MRE11, RAD50, NBS1 and 53BP1 are required for APBs 
formation (Jiang et al., 2007).  
Since they are present only in ALT-postive cells, APBs can be 
used as marker for ALT, and it has been proposed that they might 
have a role in the ALT mechanism itself. One hypothesis is that 
APBs may focus, localize, or modify proteins that are required for 
the ALT mechanism. Another possibility is that they are involved 
in removing products of the ALT process, or that APBs have the 
function to repair telomeric DNA. However, a recently published 
work shows that APBs can be found in growth arrested/senescent 
cells and cells with “closed” telomeric chromatin, which is likely 
to repress recombination, suggesting that there is no simple 
correlation between the levels of  ALT activity and the number of 
APBs or APB-positive cells. In this work, activation of p53 in p53-
negative ALT cells induced up-regulation of p21 and caused 
senescence, accompanied by the increase of APB formation. 
Moreover, three members of the heterochromatin protein 1 (HP1) 
family, involved in chromatin silencing, have been found in APBs 
(Jiang et al., 2009). The SMC5/6 complex, member of the 
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Structural Maintenance of Chromosomes (SMC) and required for 
DNA damage repair (Lehmann et al., 1995), localizes to APBs. 
The SMC5/6 component MMS21, a small ubiquitin-like modifier 
(SUMO) ligase, is required for APB formation and is necessary 
and sufficient for the SUMOylation of several subunits of the 
shelterin complex. SUMOylation of shelterin may cause transient 
disassembly of the complex and provide a mechanism to facilitate 
telomere recombination in ALT cells by uncovering them. 
SMC5/6-knockdown affects telomere length and causes increase of 
chromosome free ends and end-to-end fusions (Potts and Yu, 
2007).  
Cellular immortalization depends on the aberrant expression of 
different genes, including repressors of any telomere maintenance 
mechanism (telomerase or ALT-mediated). Repressors of ALT 
activity are present in normal and some telomerase-positive cells, 
as demonstrated by the observation that ALT activity is repressed 
in some hybrid cells formed by fusing an ALT-positive cell and a 
telomerase-positive cell (or a normal cell) (Perrem et al., 1999). In 
contrast, ALT cells may contain a repressor of telomerase, because 
hybrids of ALT cells and some telomerase-positive cells show 
ALT activity and repression of telomerase (Katoh et al., 1998). The 
absence of telomerase activity from ALT cells correlates with lack 
of expression of the hTERT subunity, and sometimes hTER. This 
is associated with methylation of the hTERT CpG island (Dessain 
et al., 2000), and with promoter methylation in the hTERC gene, 
that encodes for hTER (Hoare et al., 2001). The expression of 
exogenous telomerase in ALT cells is usually compatible with 
ALT activity (Perrem et al., 2001). 
However, in one study, the expression of telomerase in an ALT 
cell resulted in reduced ALT activity (Ford et al., 2001). One 
possibility is that ALT may be switched off in some cells, or that 
ALT and telomerase may compete for common molecular 
components, or for the access to the telomere. Another explanation 
is that in ALT cells events of telomere lengthening occur when 
telomeres shorten to a critical length, although with low frequency, 
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due to the presence of an exogenous telomerase that lengthens the 
shortest telomeres.  
The telomere length in ALT cells changes in a dynamic way, 
with fluctuations occurring on individual telomeres during cellular 
proliferation. Telomeres undergo gradual shortening at a rate of 
30-50 bp per cell division (which is similar to cells without any 
telomere maintenance mechanism), until they reach a critical 
threshold of 200 bp of telomeric repeats. When this happens, 
telomeres undergo a rapid and heterogeneous increase in length, 
sometimes of >23 kb. In some cells, telomere lengthening occurs 
in telomeres that did not appear to be critically short. This dynamic 
change in length is consistent with a mechanism mediated by 
recombination (Murnane et al., 1994). In support to this 
hypothesis, other organisms have shown to rely on the 
recombinational process for telomere maintenance, like the 
mosquito malarial vector, Anopheles gambiae, and some species of 
yeast (Nosek et al., 1998; Roth et al., 1997).  
Several models have been postulated describing inter-telomeric 
recombination, or mechanism mediated by T-loops or circular and 
linear (ECTR) (Tokutake et al., 1998). 
 
 
1.5. The epigenetic regulation of telomeres  
 
 
Recent studies have shown that epigenetic regulation of the 
telomeric chromatin regulates telomere function and maintenance. 
Pioneer studies in yeast and Drosophila melanogaster revealed the 
presence of a repressive chromatin environment at telomeres, 
which is implicated in telomere homeostasis. Like yeast and fly 
telomeres, mammalian telomeres are now thought to exist mainly 
in an heterochromatic conformation. 
The first evidence of a repressive environment at yeast 
telomeres came from the observation that telomeric chromatin can 
silence nearby genes when introduced into S. cerevisia 
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subtelomeric regions (Gottschling et al., 1990). This phenomenon 
is referred to as Telomere Position Effect (TPE). In budding yeast, 
TPE involves Rap1, a protein that binds the telomeric DNA duplex 
and recruits the Sir proteins to telomeres, spreading them to 
subtelomeric regions, where they interact with the amino-terminal 
tail of histones H3 and H4. The NAD-dependent histone 
deacetylase activity of Sir2 can deacetylate histones H3 and H4, 
with preference for acetylated lysine 16 of histone H4, and it is 
essential in promoting heterochromatin and the spreading of 
telomere silencing towards more centromeric regions (Hecht et al., 
1995). In budding yeast, telomere silencing positively regulates 
telomere length, because several mutations that disrupt telomeric 
silencing also decrease the length of telomeres.  
In fission yeast, the telomere structure is very similar to that of 
mammals. Clr4 (an orthologue of mammalian Suv39h HMTases) is 
involved in the methylation of H3K9, which creates a binding site 
for Swi6 (the orthologue of the D. melanogaster Heterochromatin 
Protein HP1) (Nakayama et al., 2001). Experiments performed in 
D. melanogaster show that the heterochromatin protein HP1 
negatively regulates telomere elongation (Perrini et al., 2004).  
Mammalian telomeres have the ability to silence subtelomeric 
genes through TPE and, similarly to yeast, TPE in human cells is 
influenced by telomere length, increasing its activity when 
telomeres are elongated (Baur et al., 2001; Koering et al., 2002). 
Unlike in yeast, in mammalians, not only subtelomeres but also 
telomeres contain nucleosomes, with an altered spacing compared 
with the non-telomeric chromatin (Tommerup et al., 1994). Many 
markers of heterochromatin have been identified in mammalian 
telomeres, like trimethylation of H3K9 and H4K20. The enzymes 
responsible of H3K9 methylation are SUV39H1 and SUV39H2 
(Garcia-Cao et al., 2002), homologues of the yeast Clr4, whereas 
SUV4-20H1 carries out the methylation of H4K20 (Kourmouli et 
al., 2004). The retinoblastoma (RB) family of tumour suppressor 
proteins, in addition to their role as transcriptional repressors, also 
interacts with SUV420H1 and SUV420H2 to maintain 
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trimethylation of H4K20 (Gonzalo and Blasco, 2005). H3K9me 
provides a high-affinity-binding site for HP1, a repressive 
chromatin marker which is usually enriched in telomeres and 
subtelomeres  (Fig.8). Mammalian telomeric and subtelomeric 
repeats are characterized by low levels of acetylated H3 (AcH3) 
andH4 (AcH4) (Benetti et al., 2007). 
 
 
 
Figure 8. Epigenetic modifications at mammalian telomeric regions. Telomeric and subtelomeric 
regions are enriched in trimethylated H3K9 and H4K20, and HP1 isoforms. In addition, 
subtelomeric DNA is heavily methylated by the DNMT1, DNMT3a and DNMT3b enzymes. Both 
histone trimethylation and DNA methylation act as negative regulators of telomere length. DNA 
methylation also inhibits telomere recombination. (Blasco 2007) 
In contrast to budding yeast, which lacks DNA methylation, in 
mice and humans the subtelomeric regions are methylated. 
Mammalian telomeres cannot be methylated because they lack 
CpG sequences, substrates for DNA methyltransferases (DNMTs). 
DNA methylation regulates the accessibility of DNA- binding 
factors and the remodelling of chromating, thereby exercising a 
key role in the regulation of transcription. DNA methylation at 
subtelomeres might also reinforce TPE.  
Defects in histones and DNA modifications at telomeres 
correlate with loss of telomere-length control. Loss of SUV39H1 
and SUV39H2 HMTases induce decreased levels of H3K9 
trimethylation and telomere elongation (Garcia-Cao et al., 2004). 
Aberrant telomere elongation is also observed in cells that lack all 
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the members of the retinoblastoma family with consequent 
decreased levels of H4K20 trimethylation (Garcia-Cao et al., 
2002). DNA methylation represents an additional way to control 
telomere length, and demethylation of subtelomeric regions results 
in dramatically elongated telomeres and increased homologous 
recombination (Gonzalo et al., 2006).  
 
  
 
Figure 9. Model for the role of epigenetic modifications in telomere-length control. Telomeres 
and subtelomeres have a compacted and ‘close’ conformation. Telomere shortening leads to decrease 
of heterochromatic marks and increase of histones acetylation, resulting in a more ‘open’ chromatin 
state, which allows accessibility of telomerase and proteins involved in telomere recombination by 
ALT mechanism. Once telomeres are elongated, they can be newly assembled into heterochromatin. 
(Blasco 2007) 
 
 
Shortening of telomeres that occurs during cell divisions and 
ageing results in a decreased density of heterochromatin marks, 
and an increased density at telomeric repeats and subtelomeres of 
marks that are characteristic of ‘open’ chromatin. This status could 
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favour the activation of telomere-elongation mechanisms, like 
telomerase and ALT (Fig.9). 
In conclusion, histone and DNA methylation have an important 
role in regulating mammalian telomere length, and vice versa, 
telomere length dictates the assembly of heterochromatin domains 
at telomeres. This model could explain the link between cancer and 
aging. The shortening of telomeres  that normally happens during 
aging, might results in epigenetic defects at telomeres, which in 
turn could favour the activation of the telomere maintenance 
machinery and allow cancer development.  
 
 
1.6. Telomeres and DNA-damage response. 
 
 
Various proteins involved in the DNA-damage response (DDR) 
physically associate with telomeres and play important roles in 
regulating normal telomeric functions.   In fact, progressive 
attrition or uncapping of telomeres elicit a DNA-damageresponse 
as a result of the inability of the cell to distinguish dysfunctional 
telomeric ends from DNA double strand breaks (d'Adda di 
Fagagna et al., 2004). 
Cells have evolved specific mechanisms to recognise sites of 
DNA damage and to promote the recruitment of DNA-repair 
proteins. When DNA damage is present, checkpointes are activated 
and the  cell-cycle progression is slowed down or arrested to 
favour  DNA damage repair . Once the DNA damage has been 
removed, cells resume their proliferation.  
The inability to repair DNA damage leads to programmed cell 
death (apoptosis) or causes the entrance into permanent cell cycle 
arrest (senescence). Central in the DDR are two protein kinases of 
the PIKK (Phosphatidil Inositol 3-Kinase-like Kinase) family, 
ATM and ATR, with distinct but partially overlapping functions 
(Shiloh, 2003). These kinases are activated by DNA damage-
binding proteins, like RPA or the MRE11-RAD50-NBS1 (MRN) 
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complexes (Uziel et al., 2003), which act as “sensors” of damage. 
Once activated, ATM and ATR phosphorylate a range of factors, 
including the checkpoint kinases ChK1 and ChK2, that then target 
various effectors involved in DNA repair and cell-cycle 
progression (Bartek et al., 2007).  
Another target of PIKKs is the histone H2AX, which is 
phosphorylated (γ-H2AX) extensively in the chromatin flanking 
the sites of damage (Fernandez-Capetillo et al., 2004). γ-H2AX 
induces changes in the chromatin structure that facilitate the 
accumulation of DNA-repair andcheckpoint proteins, favouring the 
DDR (Fig.10). 
 
 
 
Figure 10. DNA damage response signaling pathway. Double-strand breaks are recognized by the 
MRN (Mre11-RAD50-NBS1) complex and lead to the activation of ATM. Activated ATM 
phosphorylates a range of substrates, including ChK2, p53 and H2AX. Other forms of DNA damage 
lead to the generation of single stranded regions that become coated with replication protein A 
(RPA). This attracts ATR, which phosphorylates downstream substrates, including ChK1, p53, 
MDM2. (Meek 2009) 
 
 
DNA double-strand breaks (DSB) are the most deleterious 
among DNA modifications. DSBs are repaired by homologous 
recombination (HR, predominant in prokaryotes) or non-
homologous end-joining (NHEJ, the major pathway in eukaryotes).  
NHEJ is the predominant mechanism and can join any two 
exposed double-stranded DNA ends. Main components of NHEJ 
are the LigaseIV/XRCC4, Ku complex and DNA-dependent 
protein kinase catalytic subunit (DNA-PKcs). LigaseIV/XRCC4 is 
recruited to DNA ends via interaction with Ku and it is responsible 
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for NHEJ ligase activity (Grawunder et al., 1997). The Ku complex 
is an heterodimer comprising the Ku70 and Ku86 (also known as 
Ku80) subunits, that possesses high affinity for dsDNA ends, and 
is implicated in alignment and synapsis of DNA ends and 
recruitment of additional factors important for the processing of 
DNA breaks (Dynan and Yoo, 1998). DNA-PKcs is a member of 
the phosphoinositide-3-kinase-related (PIKK) family, which 
physically associates with the Ku heterodimer forming a 
catalytically active DNA-PK holoenzyme (Fig.11).  
 
Figure 12. Simplified overview of non-homologous end-joining. NHEJ brings the ends of the 
broken DNA molecule together by the formation of a synaptic complex, consisting of two DNA 
ends, two Ku70/Ku80 and two DNA-PKcs molecules. Non compatible DNA ends are processed to 
form ligatable termini, followed by repair of the break by the LigaseIV/XRCC4 complex. (Weterings 
and Chen 2008) 
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The DNA-PK complex has a serine/threonine kinase activity. 
Ku recruits DNA-PKcs to a DSB, leading to a rapid activation of 
DNA-PK in response to DNA damage (Falck et al., 2005). The 
activation of this kinase appears to require a direct interaction of 
DNA-PKcs with free DNA. Little is known about DNA-PKcs 
function in DSB rejoining or its phosphorylation targets.  
In vitro studies indicate that autophosphorylation of DNA-PKcs 
is critical for a correct NHEJ, confirming a role for DNA-PKcs in 
DNA ligation through remodelling of the DNA ends by DNA-PK 
complexes (Block et al., 2004a). DNA-PK phosphorylates histones 
H2AX and H1, and in this way it  facilitates the NHEJ reaction by 
modifying the local chromatin environment to provide access to 
other DNA repair complexes at DSBs (Kysela et al., 2005). DNA-
PK also recruits Artemis, a structure specific endonuaclease that 
mediates ligation of the ends (Ma et al., 2005). 
 
1.6.1.  DNA damage response proteins at functional telomeres. 
 
As previously mentioned (see above paragraphs), DNA damage 
response factors associate with telomeres (MRN complex, DNA-
PK, ATM and ATR). A role for these proteins at telomeres is 
confirmed by the observation that their inactivation leads to 
telomere dysfunctions. For example, inactivation of ATM causes 
telomere shortening (Metcalfe et al., 1996), and also RPA has been 
implicated in the control of telomere length because it facilitates 
the recruitment of ATR (Zou and Elledge, 2003). These data 
suggest that a PIKK-mediated checkpoint is necessary for normal 
telomere homeostasis. As reported in yeast, a role for the MRN 
complex in telomere maintenance may exist in mammals, as NBS1 
associates with telomeres during S phase when telomeres are 
elongated and is required for effective telomere elongation by 
telomerase (Ranganathan et al., 2001). There are evidences that 
components of NHEJ also have a function in telomere maintenance 
in mammals. In fact, immunoprecipitation studies have revealed a 
physical association of Ku with telomeres (d'Adda di Fagagna et 
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al., 2001). Accordingly, inactivation of one allele of the Ku86 gene 
in human cells results in telomere shortening (Myung et al., 2004), 
while inactivation of both alleles leads to cell death (Li et al., 
2002). One study shows that mice lacking Ku80 and embryonic 
stem cells lacking Ku70 have shorter telomeres, chromosome 
instability and fusions (d'Adda di Fagagna et al., 2001), however, 
another group reports contrasting data showing that inactivation of 
Ku80 does not lead to telomere shortening and that the 
chromosomal fusions retain telomeric DNA at fusion points 
(Samper et al., 2000). 
The third subunit of the DNA-PK complex, DNA-PKcs, also 
contributes to the protection of telomeres. DNA-PKcs associates 
with telomeric DNA in human cells (d'Adda di Fagagna et al., 
2001), and inhibition of the catalytic activity of DNA-PKcs 
through inactivation of one or both alleles, or by treatment with 
chemical inhibitors results in telomere shortening, genomic 
instability and telomere fusions (Bailey et al., 2004). Mouse 
embryo fibroblasts (MEFs) from DNA-PKcs-/- mice or cells from 
severe combined immunodeficient (SCID) mice, expressing a 
defective DNA-PKcs gene, show a significant increase in end-to-
end fused chromosomes (Goytisolo et al., 2001), supporting the 
hypothesis that DNA-PKcs is involved in telomere capping. Since 
NHEJ is severely impaired in DNA-PKcs-/-, Ku70-/- and Ku80-/- 
mice, it will be interesting to determine which pathway is 
responsible for the observed fusions. It has also been shown that 
mice lacking DNA-PKcs and Terc undergo telomere loss with 
faster rates than mice lacking Terc alone (Espejel et al., 2002). 
This data support a role for DNA-PK in telomere homeostasis, 
both in end-capping and in the maintenance of telomere length.  
A crucial question is which factor is phosphorylated by DNA-
PKcs and what is the effect of this phosphorylation. A recent study 
shows that DNA-PK phosphorylates a telomere-associated protein, 
heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1), and that 
this phosphorylation is triggered by the telomerase RNA 
component, hTER. hnRNP A1 binds telomeric DNA in a sequence 
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specific manner, and it seems to have a critical function in 
telomere maintenance. hnRNP A1 loss causes telomere shortening, 
and it has been postulated that it may contribute to telomere 
elongation. This data suggest that hTER-mediated stimulation of 
the kinase activity of DNA-PK towards telomere-associated 
proteins might play a role in telomere maintenance (Ting et al., 
2009). 
 
 
 
 
 
1.6.2. DNA damage response at dysfunctional telomeres. 
 
When telomere function is disrupted, a DNA damage response 
is triggered, and because DNA repair activities can impair the 
integrity of chromosome ends extensive genome instability can 
arise. DNA damage response can be activated when telomere are 
rendered dysfunctional through replicative attrition of the telomeric 
DNA or by inhibition of shelterin (de Lange, 2005).  
A suitable model for the study of the DNA-damage response to 
dysfunctional telomeres is the inhibition of TRF2, which causes 
the uncapping of telomeres. TRF2 is inhibited through RNA 
interference or by expressing a dominant-negative TRF2 allele that 
binds the endogenous TRF2 and forms an inactive heterodimer, 
unable to bind the DNA (de Lange, 2002; van Steensel et al., 
1998). This allele, named TRF2ΔBΔM, blocks the accumulation of 
TRF2 on chromosome ends and effectively strips TRF2 and its 
interacting factors off the telomeres (Li et al., 2000; van Steensel et 
al., 1998). 
Uncapped telomeres associate with DNA damage response 
factors such as 53BP1, γ-H2AX, Rad17, ATM and MRE11. These 
foci of DNA damage factors that co-localize with TRF1, are 
referred to as Telomere Dysfunction-Induced Foci (TIFs) (Takai et 
al., 2003) (Fig.12). TIFs are used as markers for telomere 
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dysfunction. The ATM kinase is the main transducer of the 
telomere damage signal. 
 
 
 
Figure 12. DNA damage response at dysfunctional telomeres. Inhibition of shelterin subunits 
causes loss of protection of telomeres, that become associated with DNA damage response factors, 
forming TIFs. Telomere damage activates ATM kinase, which leads to a p53-dependent G1/S arrest 
and can induce either apoptosis or senescence. (de Lange 2005) 
 
However, telomere-directed senescence and TIFs formation is 
not abrogated in ATM-deficient cells, supporting the idea that 
dysfunctional telomeres might also induce an ATM-independent 
pathway (Takai et al., 2003). Recently published data postulate a 
mechanism in which TRF2 represses ATM kinase, while POT1 
represses ATR kinase (Fig.13). This model may provide an 
explanation for how cells detect critically shortened telomeres: as 
the abundance of shelterin at telomeres depends on the length of 
the duplex telomeric repeats, short telomeres contain less TRF2 
and POT1, leading to the expression of the ATM and ATR kinases 
and resulting in cell cycle arrest and DNA repair at telomeres 
(Denchi and de Lange, 2007). Inhibition of TRF2 leads to the 
formation of many fused telomeres, because of the rapid loss of the 
3’overhang which mediates NHEJ (van Steensel et al., 1998) 
(Fig.14). Cells expressing TRF2ΔBΔM show end-to-end fused 
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chromosomes, usually chromatid-type dicentrics, involving the 
leading strand (Bailey et al., 2001). 
 
 
Figure 13. Model for repression of DNA damage response at telomeres. ATM and ATR are 
independently repressed by TRF2 and POT1. NHEJ is repressed by TRF2. NHEJ of telomeres 
lacking TRF2 is stimulated by either ATM or ATR signalling. (Denchi and de Lange 2007) 
 
This observation indicates that in the absence of TRF2, cells fail 
to regenerate the 3’ overhang and the ends created by leading 
strand synthesis remain blunt ended after DNA replication. 
Dicentric chromosomes are generally unstable in mitosis. The two 
centromeres of a dicentric chromosome can attach to opposite 
poles, forming an anaphase bridge, which requires the formation of 
breaks in the chromosomes to allow for cell division.  Therefore, 
TRF2 inhibition generates genomic instability, with translocations, 
rearrangements and changes in chromosomes number 
(Smogorzewska et al., 2002).  
The consequences of TRF2 inhibition and DNA damage 
response activation can be different depending on the cell type. In 
many cell types, including primary lymphocytes, TRF2 inhibition 
leads to immediate induction of apoptosis (Karlseder et al., 1999). 
Apoptosis is accompanied by the stabilization and activation of 
p53, resulting in expression of its downstream targets p21 and bax. 
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The ATM kinase is required for the initiation of this program and 
cell lines lacking this kinase escape apoptosis after TRF2 
inhibition. In a subset of human cell types, especially in primary 
fibroblasts, TRF2 inhibition results in onset of senescence rather 
than apoptosis (Karlseder et al., 1999) (Fig.14). 
 
Figure 14. Cellular consequences of telomere deprotection due to inhibition of TRF2. 
TRF2ΔBΔM binds endogenous TRF2, forming a dimer unable to bind telomeres. Unprotected 
telomeres activate different pathways depending on the cell type. (de Lange 2002) 
 
The activated pathways involve upregulation of p53 and its 
target p21, and repress Rb phosphorylation with a consequent 
induction of the CDK inhibitor, p16. Inhibition of p53 alone or 
pRb alone, fails to abrogate the cell cycle arrest induced by 
TRF2ΔBΔM, indicating that both tumour suppressors are capable of 
preventing entry into S phase when telomeres are damaged 
(Fig.14). Also in the senescent pathway the ATM kinase is 
involved in the signalling upstream of p53 and Rb. However, 
fibroblasts from ataxia telangestatica (A-T) patients, which are 
deficient for this kinase, are able to enter senescence after 
TRF2ΔBΔM induction, probably implicating other kinases as ATR 
or DNA-PKcs  (Fig.14).  
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1.7. Telomere, the molecular clock in aging and cancer. 
 
The progressive shortening of telomeres is at the basis of 
cellular senescence, a mechanism involved in organism aging and 
protection against cancer. The mechanisms that can trigger 
senescence are the accumulation of DNA damage, the epigenetic 
deregulation of the INK4a/ARF locus which encodes the tumour 
suppressors p16INK4 and ARF (these proteins increase with aging 
and are a barrier to the outgrowth of cancer), and the shortening of 
telomeres (Collado et al., 2007) (Fig.15).  
The contribution of telomere shortening in aging has been 
established following several observations. First of all, many 
studies have described an inverse correlation between telomere 
length and age in a variety of tissues (Cawthon et al., 2003; Ogami 
et al., 2004; Panossian et al., 2003). Secondly, factors that are 
considered to accelerate aging, such as stress, smoking and obesity, 
have been shown to negatively affect telomere length (Canela et 
al., 2007; Epel et al., 2004; Valdes et al., 2005).  
It should also be taken into account that telomere shortening is 
accelerated by oxidative damage, which is also associated with 
aging (von Zglinicki and Martin-Ruiz, 2005). Therefore, telomere 
shortening could reflect not only the proliferative history of a cell, 
but also the accumulation of oxidative damage. In addition, several 
human premature aging syndromes are linked to mutations in 
telomerase or in proteins that directly affect telomere activity and 
result in accelerated rates of telomere shortening. These include 
dyskeratosis congenital (DC), aplastic anemia and idiophatic 
pulmonary fibrosis. Other premature aging syndromes are 
characterized by accelerated rate of telomere shortening, and are 
triggered by mutations in DNA repair proteins such as Nbs1 
(Nijmegen breakage syndrome), Mre11 (ataxia telangiectasia-like 
disorder), WRN (Werner syndrome), BLM (Bloom syndrome), 
ATM (Ataxia telangiectasia) and proteins encoded by FANC genes 
(Fanconi anemia) (Blasco, 2005b).  
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Another demonstration that telomere shortening is one of the 
causes of cellular senescence comes from the observation that re-
introduction of the TERT telomerase gene is sufficient to bypass 
replicative senescence and to confer immortal growth to a number 
of human primary cell lines (Bodnar et al., 1998). 
 
 
 
Figure 15. Multiple mechanisms that trigger senescence. Telomere shortening, derepression of 
the INK4a/ARF locus, and the accumulation of DNA damage operate during the lifespan of the 
organism. The final result is age-dependent loss of stem cell functionality and an age-dependent 
increase in the number of senescent cells in differentiated tissues (represented as blue cells). 
Tumours may arise at any point in life, but the stress signals characteristic of tumours will engage 
the senescence program. This tumor-specific senescence constitutes an important barrier to tumor 
progression. (Collado et al. 2007) 
 
One of the best tools to study of the impact of short telomeres 
on aging is the telomerase-deficient mouse model. Terc-deficient 
mice were first generated by elimination of the mouse Terc gene 
(Blasco et al., 1997). Terc-/- mice show shortened lifespan (even at 
the first generation), infertility, heart failure, immunosenescence, 
decreased regeneration of the digestive system, the skin, and the 
hematopoietic system (Lee et al., 1998; Leri et al., 2003). 
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Dysfunctional telomeres in Terc-deficient mice are detected as 
damaged DNA, triggering cell cycle arrest and apoptosis. The 
pathologies developed by telomerase-null mice recapitulate human 
deseases associated with aging. Telomere-driven aging could be 
the consequence of the accumulation of senescent cells, or of the 
loss of stem cell function. For example, abundant senescence cells 
(as measured by senescence associated β-galactosidase activity, SA 
β-gal) have been observed in the liver of telomerase null mice 
(Satyanarayana et al., 2003).  
 
Figure 16. Telomere shortening, aging and cancer. Primary cells divide and telomeres shorten 
until they reach a critical length that triggers senescence (blue). Activation of telomerase before 
senescence allows cells to divide indefinitely and maintain a stable genome (green). If RB and p53 
are suppressed, cells continue dividing (orange) arriving to telomeric crisis, characterized by a 
massive genomic instability and cell death (dark pink). If telomerase is activated before erosion is 
completed, this re-establishes telomere maintenance and genomic stability (light pink). Activation of 
telomerase after crisis allows transformed clones to become immortal and leads to cancer (brown). 
(Verdun and Karlseder 2007) 
 
On the other hand, progressive telomere shortening in the 
context of Terc- deficient mice is responsible for the decreased 
functionality of stem cells, and is considered a barrier for stem cell 
proliferation, in turn limiting tissue regeneration (Flores et al., 
2005). The telomere clock limits not only the proliferation of 
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normal noncancerous cells, but also the proliferation of those cells 
that are already primed toneoplastic transformation. For this 
reason, all human cancers have to acquire mechanisms that ensure 
telomere maintainance, like the expression of telomerase or ALT. 
This is why the Terc-deficient mouse model has also been used to 
investigate the role of telomeres and telomerase in tumorigenesis. 
In particular, Terc-/- mice are resistant to both induced and 
spontaneous tumorigenesis (Gonzalez-Suarez et al., 2000). Mice 
that are simultaneously deficient in telomerase and the tumour 
suppressor proteins p19ARF, p16, p21, APC, ATM, DNA-PKcs, 
Ku, PARP1 and PMS2 also show reduced tumorigenesis (Blasco, 
2007). This indicates that short telomeres are a potent suppressor 
of tumorigenesis even in a tumour-prone genetic background, 
because they can induce cellular arrest and apoptosis. Two main 
exceptions to this general trend occur when lack of telomerase is 
combined with a deficiency in p53 or with overexpression of the 
telomere-binding protein TRF2 (Blanco et al., 2007). The barrier 
imposed by short telomeres is bypassed and cells proliferate in the 
presence of chromosomal aberrations, in a condition called 
“crisis”. Crisis fuels the development of cancer (Artandi et al., 
2000), because transformed clones can emerge mainly by 
activation of telomerase (Fig.16).  
This observation emphasizes the dual role of telomerase: on one 
hand, it works as an oncogene, as reactivation of the enzyme in 
cells with critically short telomeres allows for genomically 
unstable and immortal clones to be established; on the other hand, 
it is a tumour suppressor, since activation of telomerase in cells 
that have not reached crisis prevents telomere-mediated genomic 
instability, which is priming to cancer development. 
The balance between telomere length maintainance and 
preventing aberrant telomere aberration creates what we could 
refere to as “the Cancer/Ageing paradox”: stem cells need telomere 
elongation to assure tissue self-renewing, meanwhile normal cells 
needs a molecular clock that ensure stop growing allowing tissue 
regeneration.  
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2. Promyelocytic Leukemia Protein 
(PML) 
 
The study of chromosomal translocations associated with 
haemopoietic tumors has led to the identification of new genes 
putatively involved in neoplastic transformation (Sawyers et al., 
1991). 
The PML gene, also designated myl, was identified by cloning 
the breakpoint sites of the 15; 17 chromosome translocation 
associated with acute promyelocytic leukemia (APL). As a 
consequence of this balanced translocation, PML (Promyelocytic 
Leukemia Protein) fuses to Retinoic acid receptor α (RARα), 
leading to the production of two fusion genes that encode for PML-
RARα and RARα-PML chimeric proteins. Both of them coexist in 
the leukemic cells, but to date work has focused on PML-RARα 
since it retains most of the functional domains of the parental 
proteins, while little is known about RARα-PML. 
 
 
2.1. Acute Promyelocytic Leukemia (APL) 
 
Acute Promyelocytic Leukemia represents the 5-10% of all the 
Acute Myeloid Leukemias (AML) cases. According to the 
cytomorphological French-American-British classification, it 
corresponds to the M3 subtype, in which leukemic blasts are 
arrested at a promyelocytic stage of differentiation.  
The pathogenesis of acute myeloid leukemia, differently from 
other forms of cancer, is predominantly associated with 
chromosomal translocations that give rise to the formation of 
active fusion proteins. Specific subtypes of AML are associated 
with specific aberrations. Remarkably, one of the two components 
of the fusion protein is generally a transcription factor involved in 
the control of myeloid differentiation (Alcalay et al., 2001). 
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APL is associated with at least four different chromosomal 
translocations, responsible for the generation of four fusion 
proteins: PML-RARα t(15:17), observed in the vast majority of 
APL cases (95%), PLZF-RARα t(11;17) (4% of APL cases) and 
the less common, sporadically observed, NPM-RARα and NuMA-
RARα fusion proteins (Fig.17).  
 
  
 
 
 
 
Figure17. Molecular Pathogenesis of APL. APL is a common form of acute myeloid leukemia 
(AML) that, moleculary, harbors a chromosomal translocation involving the RARa gene on 
choromosome 17. To date, five different fusion partners of RARa have been identified that include 
the promyelocytic gene (PML), the promyelocytic leukemia zinc finger gene (PLZF), the 
nucleophosmin gene (NPM), the nuclear mitotic apparatus gene (NuMA) and the signal transducer 
and activator of transcription 5b gene (Stat5b). 
RARα (retinoic acid receptor α), the common denominator of 
all these translocations, is a member of the nuclear hormone 
receptor superfamily of transcription factors. Upon binding of the 
Retinoic Acids (RA), RARα transactivates target genes involved in 
hematopoietic differentiation while, in the absence of ligand, the 
transcription is repressed by the recruitment of histone 
deacetylases (HDACs), through a direct interaction between RARα 
and the co-repressors N-CoR and SMRT (Fig.17).  
In APL, the fusion protein PML-RARα aberrantly binds to 
HDACs leading to repression of transcription and consequently to 
a block of differentiation (Grignani et al., 1998).The altered 
recruitment of HDAC is due to oligomerization of the fusion 
protein through the PML moiety (Minucci et al., 2001). Differently 
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from the normal counterpart RARα, the fusion protein doesn’t 
release HDACs, even in the presence of physiological 
concentrations of retinoic acid. By contrast, high doses of RA 
cause dissociation of the PML-RARα/HDACs complex, restoring 
the normal differentiation pathway. The clinical treatment of APL 
patients with RA represents the first example of “differentiation 
therapy”. 
The block of differentiation is not the only feature of leukemia, 
which is also characterized by the abnormal proliferation of 
leukemic cells. Indeed, leukemic cells do not have cell cycle 
profiles different from that of their physiological counterparts, but 
rather they survive in conditions where a normal cell would 
undergo programmed cell death. PML-RARα associates physically 
with PML, thus potentially interfering with its function. This 
hypothesis was further corroborated by experiments carried out in 
mice. Transgenic mice expressing PML-RARα develop leukemia 
with APL features when expressed in the myeloid compartment, 
while dominant negative RARα mutant, that do not interfere with 
PML function, do not, underscoring the importance in 
leukemogenesis of the functional disruption of PML. A possible 
explanation could be that, as previously mentioned, PML is 
required for the pathological requirement of HDACs, but it is also 
possible that the leukemic fusion protein, acting as a dominant 
negative, could interfere with the growth suppressive activity of 
PML, lending the leukemic blasts a marked survival advantage. 
 
2.2.  PML Locus and Alternative Spliced PML Variants. 
The PML genomic locus spans approximately 35 Kb and is 
subdivided in nine exons. Due to alternative splicing of the gene 
transcript, which always involves coding exons, PML exists in a 
number of different isoform(Gupta et al., 1981)  (Fagioli et al., 
1992) (Fig.19). The exons implicated in the alternative splicing fall 
into two groups: central exons (4, 5 and 6) and 3’ exons (7, 8 and 
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9). All transcriptional variants share the N-terminal region, but 
differ in their central and C-terminal portions. The N-terminal 
common region to all PML isoforms (amino-acids 1-394) contains 
the region homologous to the DNA-binding finger domain of 
numerous transcriptional factors (de The et al., 1991; Kakizuka et 
al., 1991). Amino acids 228- 394 form part of another region that 
has the characteristic of a α-helix. All PML isoforms seem to have 
the potential to act as transcription factor and to form homo- or 
heterodimers. The adjacent region of a108 amino acids constitutes 
the variable central region for the alternative splicing of exons 4, 5 
and 6 and are also part of the α-helix. The different length of the 
α-helix among isoforms could influence the binding properties of 
the dimerization interface of the proteins. The next region 
corresponds to the serine/proline-rich domain retained in all PML 
isoforms. The C-terminus which follows differs in multiple 
isoforms and it’ s variably encoded by exons 7, 8 and 9 (Fagioli et 
al., 1992) (Fig.18). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure.18. Exon assembly of PML isoforms. 
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On the basis of the sequence differences of the carboxy-termini, 
PML isoforms can be divided into seven groups, designed as 
PMLI-VII (Jensen et al., 2001). A further division into sub-groups 
a/b/c reflects the alternative splicing of the central exons. 
Therefore all PML isoforms share the same N-terminal part 
(amino-acids 1-552), but differ in the C-terminus portion, except 
for the shortest one, PML VII. PML VII is also the only isoform 
that doesn’t contain a nuclear localization signal (NLS). All PML 
isoforms are almost equally expressed in the different cell lines 
(Fagioli et al., 1992).  
The function of the complex splicing pattern of PML is not 
known. It is possible, however that the different PML isoforms 
could provide different surfaces on which protein interactions may 
occur, thus affecting NB composition and function. 
 
2.3. PML Protein Structure 
PML is an ubiquitary expressed protein that belongs to the 
TRIM family, characterized by the presence of a TRIpartite Motif 
(TRIM). The TRIM is composed of three cysteine-rich zinc-
binding domains, a RING-finger and two B-boxes (B1 and B2), 
followed by a α-helical coiled-coil (CC) region (Reymond et al., 
2001) (Fig.19). PML, as mostly of the TRIM family members, 
forms high molecular weight complexes in vivo as a consequence 
of self-association properties of the coiled-coil region. The coiled-
coil region is responsible for the formation of stable PML 
homodimers and for the PML/PML-RARα heterodimerization 
(Grignani et al., 1998), whereas the RING-finger domain is 
involved in protein-protein interaction (Borden et al., 1995). The 
TRIM motif is essential for correct localization of PML 
localization and can by itself recapitulate the growth suppressor 
activity of the protein (Fagioli et al., 1998). 
In addition to splicing, PML is also subjected to post-
translational modifications that may increase the level of 
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complexity, either by directly affecting protein-protein interactions 
or by interfering with the ability of PML to form NBs. In fact, 
PML sequence contains three SUMO-1 modification sites (lysine 
65 in the RING finger, lys 160 in the B1 box and lys 490 in the 
NLS); they are located within the common region shared by all 
PML isoforms, suggesting a relevant role for this covalent 
modification. PML is also a phosphoprotein. It is present within 
the cell in both the phosphorylated and the unphosphorylated form. 
The treatment with alkaline phosphates, in fact, abolished the slow-
migrating band of PML in a Western Blot analysis. Moreover 
experiments of 32P incorporation, followed by complete hydrolysis 
and thin layer chromatography demonstrated that PML is 
phosphorylated at both tyrosines and serines, but not at threonine 
residues (Chang et al., 1995). Recently it has been described a 
PML post translation regulatory mechanism depending by the 
serine/threonine casein kinase 2 (CK2) activity.  
 
 
 
 
 
 
 
 
Figure 19. PML Protein Structure. All PML isoforms share the N-terminal region which contains 
the RING finger domain, two B boxes and a predicted a-helical Coiled Coil domain (RBCC motif). 
The seven different C-termini derive from an alternative use of 3’ exons, resulting in different size of 
the isoforms. All isoforms contain three characterized SUMOylation sites (S) (amino acid position 
65 in the RING finger, 160 in the B1-Box and 490 in the NLS) and a nuclear localization signal 
(NLS). 
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CK2-mediated PML phosphorylation at the serine 517 of the 
serine/proline-rich domain is critical in the PML ubiquitylation and 
degradation upon cellular stress (Scaglioni et al., 2006). 
In APL the PML locus on chromosome 15 can be alternatively 
disrupted in three different sites (breakpoint cluster regions-bcr): 
bcr3 into the third intron, bcr1 into the seventh intron and bcr2 into 
exon 6. The resulting PML-RARα proteins contain the N-terminal 
part and the TRIM domain, but invariably lose the C-terminal 
domain. In this part resides a potential phosphorylation site with a 
serine/proline-rich region that could be involved in the regulation 
of the protein. Therefore the PML-RARα chimeric protein would 
be differently regulated from the normal PML protein and this 
could contribute to the pathogenesis of APL.  
 
2.4. PML and stress response pathways. 
 
In normal mammalian cells PML is primarily localized in 
multiprotein nuclear complexes referred as PML Nuclear Bodies 
(NBs). They are discrete nuclear sub domains associated to the 
nuclear matrix. By immunofluorescence, NBs appear as spheres of 
various sizes (from 0.2 to 1µm), in number of 10-20 per nucleus 
and present in almost every type of cell studied (Fig.20). Electron 
microscopy analysis revealed the doughnut shape of these 
structures and the localization in the interchromosomal spaces. 
These structures were originally identified as autoantigens in 
patients affected by primary biliary cirrhosis. Subsequently they 
have been fascinating researchers for a long time because of their 
disruption in the leukemic blasts of APL. The expression of the 
PML-RARα fusion protein causes the delocalization of PML NBs 
into a multitude of small punctate structures described as 
microspeckles. The treatment with retinoic acids leads to clinical 
remission correlated with NBs reformation. These findings 
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strongly suggest that the integrity of PML NBs could be critical for 
normal cellular functions. 
 
 
 
 
 
 
Figure 20. PML Nuclear Bodies. PML is a part of a multiprotein complex called PML Nuclear 
Bodies, ND10 or PODs (PML oncogenic domains). It is a heterogeneous group of multi-protein 
complexes which localizes specifically in the nucleus with a typical micro-speckled pattern. a) 
Immunofluorescence of PML in a fibroblast cell line (WI38) with an antibody (PG-M3) which 
recognizes all PML isoforms. b) DAPI coloration to show the nuclear protein localization. 
In addition to PML, a high number of proteins involved in a 
variety of different cellular functions are represented in the Nuclear 
Bodies and including Sp100 (Maul et al., 1995), Blm (Ishov et al., 
1999), p53 and Rb (Alcalay et al., 1998), (Ferbeyre et al., 2000), 
(Fogal et al., 2000), (Pearson et al., 2000). DNA damage repair 
genes, such as Mre11 and NBS (Lombard and Guarente, 2000) and 
transactivators such as CBP/p300 (Boisvert et al., 2001). In many 
cases, colocalization of the mentioned NBs components with PML 
is not complete, further underlying the dynamic nature of these 
nuclear sub domains.  
A number of tumors and tumor-derived cell lines are 
characterized by a novel form of PML NBs, termed ALT-
associated PML Bodies (APBs), in which PML localize at the 
telomere together with others telomere binding proteins to 
maintain telomerase length (see below for details). 
Genetic evidences indicate that the structure of PML-NBs 
depends on the presence of PML (Ishov et al., 1999). In cells 
derived from PML knock-out mice, PML NBs do not exist and all 
protein normally targeted to these domains are nuclear diffuse or 
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concentrate in distinct domains. The product of the BLM gene, for 
instance, which is inactivated in the Bloom syndrome, is normally 
found to co-localize with PML in the nuclear bodies. By contrast, 
in PML null cells BLM is no longer found in these structures 
(Zhong et al., 1999).  
The PML SUMOylation is also required for PML-NB-
formation (Ishov et al., 1999), (Wang et al., 1998b), (Zhong et al., 
2000), and, in fact, many of the proteins found in the PML NBs are 
SUMOylated (Seeler and Dejean, 2003). Recently it has been 
demonstrated that a SUMO binding site in PML, independent of its 
sumoylation sites, and the PML Ring domain, is necessary for 
PML-NB formation. The sumoylated PML through the sumo 
binding motif could constitutes the first step for subsequent 
recruitment of sumoylated proteins and proteins containing sumo 
binding motifs to the PML NBs (Shen et al., 2006). 
 
 
 
 
 
 
 
 
Figure 21. PML Nuclear Bodies respond to many cellular stress. A. UVC treatment induces a 
reorganization of PML NBs into a micro speckled patterns. B. PML NBs are modified upon ionizing 
radiation. An overall increase in the number of PML NBs are observed by indirect 
immunofluorescence of endogenous PML in WI38 after irradiation and recovered at 37C for 12h 
before fixation and anti PML immonostaining.C.RASV12 expression increases the number and size 
of the PML NBs and these changes are accompanied by increase in PML protein levels. Indirect 
immonofluorescence of PML in WI38 cell line infected with the empty vector or RASV12 4 days 
after selection. 
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The morphology of PML NBs is altered by environmental 
stresses and by a variety of viruses. Heat shock (Maul et al., 1995), 
heavy metals such as Cadmium (Nefkens et al., 2003), gamma and 
ultraviolet radiations and oncogenes, such as Ras (Pearson et al., 
2000), cause PML-NBs to disperse (Fig.21). 
PML NBs are also affected by infections of the cell with various 
DNA or RNA viruses and are disrupted during the early phases of 
the infection. Additionally PML is up regulated by interferon, an 
antiviral agent. An increased PML expression is also observed in 
inflammatory tissues and is associated with inflammatory disorders 
such as hepatitis. This suggests that PML and PML NBs could be 
involved in the cellular defense pathway against viral infections. 
Notably PML ko mice are highly susceptible to infections. 
Additionally, it was recently shown that, in hypoxia conditions, 
the mammalian target of rapamycin (mTOR) localizes into the NBs 
as well (Bernardi et al., 2006). Indeed, normally, mTOR shuttles 
between the cytoplasm and the nucleus. Upon hypoxia and 
hypoxia-mimetic agents, mTOR localizes mainly in the nucleus, 
and, in particular at the NBs level. PML would act as a negative 
regulator of mTOR itself, leading to a decrease of the transcription 
factor HIF-1α (hypoxia-inducible factor 1α) synthesis and 
consequently to a block of neovascolarization. 
Accordingly, in PML ko cells show a defect in mTOR nuclear 
accumulation and PML -/- tumors have increased angiogenesis. 
In conclusion, the presence of proteins involved in DNA repair 
and cell cycle control (Negorev and Maul, 2001) (Hofmann and 
Will, 2003) within the nuclear bodies and the dynamic response of 
the latter to a variety of stresses imply that PML NBs may exert 
multiple roles in the cellular stress response. 
Several models have been proposed for the function of PML 
bodies. In the first model, PML NBs have no direct function but 
represent aggregates of excess nucleoplasmic protein (Negorev and 
Maul, 2001). In a second model, the bodies may function as sites 
of post-translational modification and degradation of proteins. In a 
third model, PML NBs may function as sites of specific nuclear 
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events, such as transcriptional regulation, DNA replication and 
viral defence. Nevertheless, despite the large number of studies 
carried out, the physiological role of NBs within the cell is still 
under debate. 
A cytoplasmic PML isoform, in which a nuclear export 
sequence (NES) in exon 9 is retained, is also generated as a 
consequence of the alternative splicing. This isoform can shuttle 
between nucleus and cytoplasm and it’s not localized at NBs. In a 
recent work, this cytoplasmic PML protein has been implicated in 
the modulation of TGF-β signaling (Lin et al., 2004). 
 
2.5. PML Function 
The study of mice in which PML has been inactivated by 
homologous recombination has led to the conclusion that the PML 
gene is not required for viability, at least in mouse. PML ko mice 
develop normally and do not get spontaneous cancers. However 
these animals are more sensitive to tumor promoting agents. When 
exposed to the tumor initiator dimethylbenzanthracene (DMBA) 
followed by treatment with the tumor promoter 12-o-
tetradecanoylphorbol-13-acetate (TPA), PML null mice developed 
skin papillomas at a much higher frequency than wild type 
controls. Moreover, the injection of DMBA into the salivary 
glands, a procedure that normally produces sarcomas and 
fibrosarcomas in wild type animals, in PML-/- mice induced more 
tumors with a different spectrum: T and B lymphomas and 
malignant fibrohistiocytomas (Wang et al., 1998a). PML can 
therefore antagonize the initiation, promotion and progression of 
tumors of different histological origins, behaving in vivo as a tumor 
suppressor. Consistent with these findings, the over expression of 
PML inhibits the transformation of rat embryo fibroblasts induced 
by Ha-Ras expression in combination with oncogenic mutants of 
p53 or c-Myc (Mu et al., 1994) and a dramatic drop in the capacity 
of the cell lines to form colonies in a typical colony formation 
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assay (Fagioli et al., 1998). PML can exert its growth suppression 
activity either through the induction of apoptosis or replicative 
senescence.  
 
2.5.1. PML and p53-dependent apoptosis.  
The first evidence that PML is involved in the apoptotic 
pathway p53-dependent comes from experiments carried out in 
PML-/- mice. These animals are resistant to lethal effects of 
ionizing radiation (Wang et al., 1998b). Accordingly PML null 
splenocytes are resistant to γ-irradiation induced apoptosis (Guo et 
al., 2000). In these cells DNA damage induced apoptosis depends 
entirely on the presence of normal p53 function. P53-/- cells, in 
fact, are completely insensitive to irradiation, while PML-/- cells 
display an intermediate phenotype, suggesting that PML may be 
required only for a proper p53 pro-apoptotic function. Upon γ-
irradiation p53 becomes stabilized and activated by post-
translational modifications that take place at several residues. The 
DNA damage checkpoint kinase Chk2 is responsible for serine 20 
modification. PML recruits Chk2 into PML NBs and enhances p53 
phosphorylation (Yang et al., 2002). Similarly, the homeodomain-
interacting protein kinase-2 (HIPK2) has been found to colocalize 
with PML within the nuclear bodies (Hofmann et al., 2002) 
(D'Orazi et al., 2002). HIPK2 is responsible for phosphorylating 
p53 on ser 46 upon ultraviolet irradiation, an event that has been 
linked to induction of apoptosis (Oda et al., 2000). A further 
enzyme affecting p53 activity and localizing to NBs is the 
herpesvirus associated ubiquitin-specific protease. A fraction of the 
main p53 regulator MDM2 was also found to be associated with 
PML NBs, in particular after the inhibition of the nuclear export  
(Lain et al., 1999). Recently it was shown that PML and MDM2 
interact (Wei et al., 2003) and that upon DNA damage PML 
protects p53 from MDM2-mediated ubiquitination and degradation 
(Louria-Hayon et al., 2003). In addition following UV irradiation 
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the two different complexes PML/p53 and PML/MDM2 take 
place, leading to p53 stabilization (Kurki et al., 2003).  
2.5.2. PML in p53-Independent Apoptosis.  
Splenocytes and hepatocytes from PML-/- mice present defect 
in apoptosis induced by Fas and TNF. These two agents induce 
extrinsic apoptotic pathways activation considered p53-
independent (Wang et al., 1998b). Since the death receptors are 
located at the plasma membrane and PML NBs reside into the 
nucleus, a protein involved in the transduction of the signal is 
necessary. DAXX is the best candidate for this role. DAXX was 
originally cloned as a Fas-interacting protein and found to act as a 
positive mediator of Fas and TNF induced apoptosis.  
Two possible models explaining the cooperation between PML 
and DAXX in regulating apoptosis exist (Bernardi and Pandolfi, 
2003). In the first one, upon Fas-ligand binding, DAXX moves to 
the nucleus where it directly interacts with PML. DAXX is a 
transcriptional repressor and PML is thought to antagonize its 
transcriptional function by titrating it in the PML NBs. Therefore 
DAXX cannot suppress anymore the transcription of anti-apoptotic 
genes and cell undergoes apoptosis. The second model proposes 
that the PML/DAXX complex is released from the nuclear bodies 
upon PML desumoylation by Supr-1 or upon DAXX 
phosphorylation by the homeodomain-interacting protein kinase 1 
(HIPK-1). The PML/DAXX complex could have transcriptional 
functions and therefore could activate pro-apoptotic genes. The 
precise mechanism, however, is still unknown.  
 
2.5.3. PML and Senescence.  
The replicative senescence described for the first time in the 
1961 by Hayflick and Moorhead is an irreversible state of cell 
proliferation arrest triggered by telomere attrition. An identical 
endpoint can be produced in response to oxidative stress, DNA 
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damage, chromatin remodeling and intense mitogenic signaling. 
These non-telomeric stimuli induce senescence, defined 
“premature” only after a few cell divisions (Serrano and Blasco, 
2001).  
The Rb and p53 tumor suppressor are important regulators of 
senescence. Senescence is accompanied by increased levels of p53 
and hypophosphorylated Rb (Atadja et al., 1995) (Shay et al., 
1991) and enforced expression of either proteins induces 
senescence in some cell types (Ferbeyre et al., 2002). The p53 is a 
transcriptional regulator controlling a wide range of genes that 
cause cell-cycle arrest, like p21, and its transcriptional activity and 
stability increased in senescent cells (Itahana et al., 2001). The p53 
can be activated by a variety of signals, some of which produce 
specific p53 post-translational modifications such as acetylation 
and phosphorylation (Appella and Anderson, 2001). A link 
between premature senescence, PML NBs and p53 has been 
established. In primary fibroblasts PML overexpression induces 
premature senescence (Fig.22) in a p53-dependent manner, since 
p53 null mouse embryo fibroblasts are protected from this effect.  
PML itself is up regulated during replicative or Ras-induced 
senescence (Pearson et al., 2000). The resulting increase in PML 
protein levels leads to a concomitant increase in number and size 
of PML NBs (Fig.21c). The expression of the activated form of 
Ras (RasVAL12) induces also the relocalization of p53 within the 
PML NBs and promotes its acetylation at lysine 382. Acetylation is 
essential for p53 biological function and is profoundly impaired in 
PML-/- MEFs.  Although PML does not possess intrinsic 
acetyltransferase activity, it directly interacts with the 
acetyltransferase CBP/p300, recruiting it to the nuclear bodies. 
Therefore PML, p53 and CBP/p300 form a tricomplex that localize 
to PML NBs, favoring in this way p53 acetylation by CBP/p300. 
In conclusion, PML is required for p53 acetylation and senescence 
upon oncogene expression. However the conclusive evidence that 
PML, like p53, is essential for the induction of cellular senescence 
upon oncogenic transformation comes from the observation that in 
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PML null cells, RasVAL12-induced senescence is drastically 
impaired. Recently, the NAD-dependent deacetylase SIRT1, a 
negative regulator of p53, has also been found in NBs. SIRT1 
binds to p53 and deacetylases specifically lysine 382, resulting in 
decreased p53-dependent transcription and PML-induced 
senescence (Langley et al., 2002). 
 
 
 
 
Figure 22. PML induces Premature Senescence. β-Galactosidase staining of Mefs infected with 
the control vector (Ctr) or PML. A cytological marker of senescence cells is the expression of a 
senescennce-associated b-galactosidase activity (SA-b-gal).Murine fibroblasts overexpressing PML, 
morphologically, become flat and enlarged and are strongly positive for SA-b-gal. 
2.5.4. PML and telomeres 
As previously mentioned a specialized type of PML NBs, called 
APBs, has been found exclusively in telomerase-negative tumours 
in which telomeres are maintained by recombination-based 
alternative (ALT) mechanisms (see above paragraphs). A list of 
recent works suggest the existence of a functional link between the 
presence of APBs and the ALT mechanism, and also a role for 
PML in telomere maintenance. 
First of all, different laboratories focused their attention on the 
dynamic interaction between telomeres and PML NBs. Telomeres 
are firmly attached to the nuclear matrix throughout the interphase, 
and are considered important for the intranuclear positioning of 
chromosomes. However, the use of a fluorescently labelled PNA 
(peptide nucleic acid) probe that specifically target the telomeric 
DNA repeats introduced in living human osteosarcoma U2OS cells 
(ALT positive), allowed to observe the telomeres dynamic in vivo 
(Molenaar et al., 2003). This study revealed that, while the 
majority of telomeres are relatively immobile and show 
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constrained diffusion in a small submicron-sized nuclear volume, a 
subset of telomeres has a much higher degree of mobility. This 
work also showed that telomeres have the ability to associate with 
each other in a dynamic manner, forming telomere clusters. 
Telomere association might provide a possibility for spontaneous 
recombination of subtelomeric DNA, which happens at high 
frequency in somatic cells (Flint et al., 1995), and for 
recombination-based interchromosomal telomeric DNA exchanges 
observed in ALT cells. In addition they observed a dynamic 
movement of telomeric DNA to relatively immobile PML NBs. 
Another recent paper focuses on telomeres mobility during 
interphase and proposes a model to explain the formation of 
complexes between telomeres and PML NBs (Jegou et al., 2009). 
The model used in this work is a U2OS cell line that have lac 
operator repeats stably integrated adjacent to the telomeres of three 
chromosomes. An autofluorescent LacI repressor bounds to the 
lacO and allows observing by fluorescence microscopy the 
telomeres movements. This study confirmed the existence of a 
majority of telomeres which move within a confined radius, and of 
a small fraction of telomeres with more extended translocations. In 
addition they inversely correlated the increased mobility with the 
length of telomere repeat sequence. The hypothesis is that upon 
shortening of telomeres, the telosome protein complex, which 
promotes interactions with other chromatin domains and mediates 
its anchoring within the nucleus, is disrupted. This event favours 
the loss of telomeres association with heterochromatin regions, and 
allows a higher mobility. The mobility of short telomeres could 
favour their association with a pre-existing PML NB. In the second 
step of the process, additional PML protein from the nucleoplasm 
is accumulated at this locus to form the typical APB structure. The 
accumulation in the PML NBs of many proteins associated with 
DNA recombination and repair activity, suggests that these 
structures could function as sites for telomere lengthening (Fig.23). 
When the number of repeats becomes sufficiently high the 
shelterin proteins can bind again to re-establish the telomere 
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complex and promote interactions with other chromatin domains to 
induce a state of low mobility, as observed for the majority of 
telomeres (Jegou et al., 2009). 
 
Figure 23. Model for APBs formation. In telomeres with sufficient repeat length the telosome 
protein complex mediates the anchoring to another chromatin domain. This results in a confined 
mobility of the telomere that is similar to that of other chromatin loci. When the telomere repeat 
length is reduced below a critical threshold, the telosome is disrupted, and the anchoring is lost. In 
this state the telomere displays a significantly extended mobility. The telomere associates with a 
PML body to form an APB complex, in which the telomere length is increased in a process that 
involves DNA recombination and repair. The telosome can reform on the extended telomere repeat 
sequence to reestablish the telomere anchoring associated with the reduced mobility state. (Jegou et 
al. 2009) 
 
In another paper of Draskovic et al., evidence that PML NBs are 
not only a marker for ALT cells, but play a direct role in telomere 
recombination was provided. This work uses an innovative 
approach to gently enlarge PML bodies in living cells without 
perturbing their organization. This technique permits to reveal that 
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PML NBs in ALT cells associate with chromosome ends forming 
clusters of 2- 5 telomeres. In this way PML NBs bring together 
chromosome ends and promote telomere-telomere interactions 
between heterologous chromosomes, providing the required 
physical proximity for recombination (Draskovic et al., 2009). 
All these works, based on innovative and sophisticated 
microscopy analysis, gave us deep information about the dynamic 
interactions of telomeres and PML NBs. In addition to these, other 
recent studies based on biochemical approaches, show PML 
interactions with factors important for telomere stability. PML IV 
in fact interact with TERT, the catalytic component of telomerase 
(Oh et al., 2009). The specificity of TERT interaction with PML 
IV isoform is due to its C-terminal region. PML IV functions as a 
negative regulator of telomerase, because cell lines stably 
expressing PML IV display decreased telomerase activity and 
shortened telomeres. It is possible that TERT recruitment to PML 
NBs, through its interaction with PML IV, could favour post-
translational modification of the protein with consequent effects on 
its activity, as in the case of p53. 
PML IV also interacts directly with TRF1 and recruits TRF1, 
and consequently telomeres, to PML NBs in ALT cells. Then, 
sumoylation of shelterin proteins by MMS21 could occur in PML 
NBs, favouring the localization of telomeres at PML bodies (Yu et 
al., 2010). Although details of the molecular mechanism of ALT 
are largely still unknown, the data suggest an essential role for 
PML IV in APBs formation. 
However, a general link between PML NBs and telomere could 
be also hypothesized for every cell types, and not only for ALT 
cells. 
PML-telomere associations remained unnoticed except for ALT 
cells containing ALT associated PML bodies. However, an up-to-
date work shows that PML bodies associate temporary with 
telomeres during their formation, in several cell types, ALT and 
non-ALT. De novo formation of PML NBs in cells in which they 
were dispersed by chemical agents, occurs mainly at telomeric 
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DNA sequences (Brouwer et al., 2009). It is probably in ALT cells 
only that newly formed PML NBs remain associated with 
telomeric DNA, while they dissociate rapidly from telomeric sites 
in other cell types. A potential explanation could be that PML is 
recruited to SUMOylated telomere binding proteins by the SUMO 
binding domain present in PML. SUMOylation of PML may than 
lead to the recruitment of more PML protein and other components 
of PML NBs. 
This study establishes a role for telomeric foci in the 
recruitment of PML protein, without still giving an explanation of 
the possible functional meaning of this event.  
It would be interesting to explore the role of PML interaction 
with telomeres, in ALT and non-ALT cells, which could give 
much insights both into the function of PML protein and in the 
regulatory pathways of telomere maintenance. 
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RESULTS AND DISCUSSION 
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1. PML is recruited to damaged telomeres 
 
1.1.  PML NBs localize to telomere in all cell types. 
 
It is well established that PML NBs are localized at telomeres in 
ALT cell lines but little is known about PML interaction with 
telomeres of normal cells, or telomerase-positive tumour cell lines. 
We investigated the localization of PML at telomeres in 
different cell types: 
  
• three normal fibroblasts (WI38, MRC-5 and MEFs); 
• three telomerase-positive cell lines (HeLa and A549 and 
U937); 
• three ALT cell lines (U2-OS, SK-LU-1 and SA-OS-2), as 
positive control of the presence of PML at telomeres. 
 
We used ImmunoFISH experiments, in which cells were stained 
with a fluorochrome-conjugated Peptide Nucleic Acid (PNA) 
probe that recognizes telomere repeat sequences in interphase 
nuclei, together with an antibody for the PML protein. 
Normal human fibroblast cells, and telomerase-positive cells 
showed some co-localizations between PML NBs and telomere 
ends (Fig.1a). The frequency of this co-localizations this cell types 
ranges from 0,36 to 5,86 co-localizations per cell. This frequency 
is less than that observed in ALT cell lines, ranging from 3,6 to 9,3 
co-localizations per cell (Fig. 1b).  
A statistical analysis in each cell type, carried out on 50 cells, 
shows that the percentage of PML NBs localized to telomeres in 
normal and telomerase-positive cells is little but consistent, 
spanning from 4% to 34% of PML NBs total number. The result 
between all the different non-ALT cell types are comparable, and 
seem independent of the number of PML spots per cells, rejecting 
the idea of random associations (Fig.2).  
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Figure 1a. Localization of PML NBs at telomeres. PML localization at telomeres is evaluated 
through an ImmunoFISH approach. Cells were stained with a probe recognizing telomeric DNA 
(red) and with anti-PML antibody (green). DNA was stained with DAPI (blue). Enlargements show 
PML NBs associated with telomeric repeats. Representative microscopy images of three different 
normal fibroblasts cell lines (at the top) and three telomerase-positive cell lines (at the bottom) are 
shown. 
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Figure 1b. Localization of PML NBs to telomeres. PML localization to telomeres is evaluated 
through an ImmunoFISH approach, as in figure 1a. Representative microscopy images of three 
different types of ALT- positive cell lines. 
 
 
Figure 2. Statistic analysis of PML/Telomeres co-localizations. ImmunoFISH staining for 
telomeric DNA and PML was performed. Fifty cells per type were scored and the number of PML 
spots or PML/telomeres associations (bold) was counted. The last column shows the percentage of 
PML NBs co-localizing with telomeres, respect to the total number of PML spots in the cell. 
 
Thus, here we demonstrate that PML NBs can be found to 
telomeres not only in ALT cells, as showed in several previous 
works, but also in normal and telomerase positive cells. 
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The small amount of PML NBs localizing to telomeres in cells 
in normal growth conditions may reflect a small subset of 
telomeres wich are in a particular physiological situation that needs 
the association with this structures. This rare phenomenon can be 
explained, for example, with the small amount of functional 
telomeres that can be recognized from the DDR machinery in cells 
at the steady state (Verdun et al., 2005). Alternatively, the 
recruitment of PML to telomeres, can be part of DNA-repair 
mechanism. In fact, it is well established that PML NBs are sites 
that act as sensors of DNA damage and stress and many DNA 
repair and checkpoint proteins dynamically localize to PML-NBs 
(Dellaire and Bazett-Jones, 2004) 
 
 
1.2. PML NBs are recruited to damaged telomeres after 
telomere-specific damage. 
 
To investingate the link between PML and the mechanisms 
involved in telomere damage response, we performed experiments 
in telomere-specific damage conditions. We took advantage of 
different systems to induce a specific damage to telomeres, 
allowing analysis of PML NBs response in different cell types: 
• expression of a dominant negative isoform of TRF2 
(telomere associated capping protein); 
• treatment with RHPS4, a G-Quadruplex that destabilize 
shelterin structure; 
• RNA interference targeting TRF2 protein; 
 
The first model system used to test this hypothesis is provided 
by HTC75, a telomerase-positive human fibrosarcoma cell line that 
expresses an inducible dominant negative allele of TRF2 
(TRF2ΔBΔM), able to bind the endogenous protein and prevent its 
association with telomeres.  
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 The truncated dominant-negative form of TRF2 is expressed in 
HTC75 in a doxycyclin-controlled inducible manner. The HTC75 
cells, cultured in a medium without doxycyclin, express the 
dominant negative TRF2 protein (doxycyclin acts as a repressor of 
gene expression in this system. On the eighth-ninth day after the 
induction, HTC75 cells underwent senescence due to telomere 
ends uncapping and shortening, and activation of the DNA damage 
checkpoint response (van Steensel et al., 1998).  
Control HTC75 cells presented a population of cells (25%) with 
10 to 30% of PML NBs co-localizing with telomeres. Remarkably, 
co-localization of PML-NBs with telomeres was found in a higher 
percentage (75%) of induced senescent cells than in control cells 
and a subset of these cells reach even 70-80% of PML co-
localizing with telomeres (data not shown). In addition, it appears 
that PML is recruited to Telomere-dysfunction Induced Foci 
(TIFs), identified as γ-H2AX/Telomere co-localizations (Fig.3a). 
Statistical analysis revealed a significant increase of PML to TIFs 
(Fig.3b). These data are the first suggestions that purpose a role for 
PML in telomere-associated DNA-damage cellular response, in 
telomerase positive tumour cells. 
 
 
 
Figure 3a. Recruitment of PML NBs to telomeres in induced senescent cells. HTC75 cells 
uninduced (control) or induced for TRF2ΔBΔM expression were stained for γH2AX (green), telomeric 
DNA (red) and PML (blue), following the ImmunoFISH protocol. A representative image reveals 
the localization of PML to damaged telomeres (telomeres occupied by γH2AX) in induced cells. 
White arrows indicate co-localizations, some of them shown in enlargements. 
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Similar results were obtained in experiments using the second 
model that we choose to induce TIFs: RNA interference of the 
telomere-capping protein TRF2. Down-regulation of TRF2 protein 
 
 
Figure 3b. Recruitment of PML NBs to telomeres in induced senescent cells. HTC75 cells 
uninduced (control) or induced for TRF2ΔBΔM expression were stained for γH2AX , telomeric DNA 
and PML, as showed in figure 3a. A statistical analysis of the number of PML/ Telomeres co-
localizations and of PML/ γH2AX/ Telomeres triple co-localizations was carried out on 50 cells per 
type. The graph represents the mean fold change. The P value is based on a two-tailed Student’s t-
test. 
has been abundantly showed to result in telomere uncapping and 
senescence or apoptosis, depending on p53 status of the cells 
(Karlseder et al., 1999; Stagno D'Alcontres et al., 2007; Takai et 
al., 2003).  
 
Figure 4. Schematic representation of the shRNA-expressing lentivirus vector pSicoR. U6: 
RNA polymerase III promoter; shRNA: a sequence able to silence the target gene, as a siRNA, has 
adapted with a loop sequence to create a stem loop (in red the Pol III terminator stretch); CMV: 
cytomegalovirus promoter; PURO: resistence for puromycin expressing cassette (Ventura et al., 
2004).  
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We used a short hairpin RNA (shRNA)-expressing lentivirus 
vector, pSicoR (Ventura et al., 2004). This system allows silencing 
gene expression as efficiently as synthetic siRNA does, and the 
shortness of shRNA avoids the antiviral response that would lead 
to nonspecific inhibition of translation and therefore cytotoxic 
effects. Moreover, lentiviral vector can be integrated into the 
genome of the cell, independently by the proliferation of the cell, 
resulting in its stable expression even in cell with low growth 
rating.  
 
 
Figure 5. PML NBs association with damaged telomeres in TRF2 knock down cells. WI38 cells 
were infected with shRNA to inhibit TRF2 protein (TRF2 KD), or with a control vector (pSR Luc). 
Cells were stained for γH2AX (green), telomeric DNA (red) and PML (blue). The representative 
image reveals the increase of localization of PML to damaged telomeres (telomeres co-localizing  
with γH2AX) in cells infected with TRF2 KD1 respect to the control. White arrows indicate co-
localizations, some of them shown in enlargements. Lower, on the left, western blotting analysis 
showing the efficiency of RNAi –mediated knock down in WI38 cells. Lower, on the right, the graph 
illustrating the statistical analysis of PML/telomeres co-localizations and triple (γH2AX 
/telomeres/PML) co-localizations, represented as fold change and carried out on 50 cells per type. P 
value is based on a two-tailed Student’s t-test. 
 
An RNA polymerase III promoter, the U6 promoter, drives the 
expression of shRNA cloned downstream. The shRNA is a short 
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stretch of inverted DNA sequence that is processed by Dicer to 
generate siRNA. Downstream of the U6 promoter and the gene 
specific targeting sequence, there is a CMV-Puro cassette in order 
to simultaneously produce shRNA and the resistence gene for 
puromycin, allowing to easily select infected cells (Fig.4).  
Different oligos were tested and two of them were chosen for 
their silencing efficiency in downregulating TRF2 protein 
expression (TRF2 KD1, TRF2 KD2), evaluated both in western 
blotting analysis and in indirect immunofluorescence assays (see 
Western Blotting in Fig.5). As a control we generated a plasmid 
containing a shRNA that targets luiciferase, a gene not present in 
mammals (pSicoR Luc). 
Different normal human fibroblasts, infected with TRF2 KD1 
and TRF2 KD2, underwent senescence in few days, as expected, 
and the number of PML NBs respect to the control (pSicoR Luc) 
increased. As for HTC75 expressing the dominant negative form of 
TRF2, also fibroblasts infected with TRF2 KD1 show an increased 
number of co-localizations of PML to telomeres, and in particular 
with TIFs (Fig.5). The same result was obtained with the other 
oligo TRF2 shRNA, TRF KD2, ruling out off-target shRNA 
effects (data not shown), but not with control shRNAs (pSicoR 
Luc). 
The third model of telomere damage is based on the G-
quadruplex ligand, RHPS4. This compound, at high doses, 
delocalizes POT1 from telomeres and induces TIFs formation in 
few hours (see introduction, paragraph 2.1.3). Normal fibroblasts 
(WI38) or ALT cells (U2OS) were treated with 1µM RHPS4 for 24 
h. After this treatment, cells show only a small increase of TIFs 
number. Even if the effects of the treatment are not as strong as for 
TRF2 protein inhibition, RHPS4 induced recruitment of PML to 
telomeres in both normal and ALT cells (Fig. 6). All together these 
data strongly suggest that PML takes part in DNA-damage 
response to dysfunctional telomeres. In conditions of generalized 
telomere damage, independently by the system used and by the 
target cellular system (normal or tumour, ALT or telomerase-
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positive), the association of PML NBs with telomeres is greatly 
enhanced. PML NBs increase in number but are also prevalently 
recruited to telomeres, because the percentage of PML NBs 
associated to damage telomeres increases respect to the total 
number of PML NBs.  
Nevertheless, microscopy analysis in living cells is necessary to 
study the dynamic association between telomeres and PML NBs 
and to elucidate if there is a redistribution of PML NBs to damage 
telomeres rather than a de novo formation of PML NBs at these 
telomeres.  
 
Figure 5. PML NBs recruitment to dysfunctional telomeres induced by treatment with RHPS4. 
WI38 normal fibroblasts and U2OS ALT cells were treated with RHPS4 1μM for 24h. Co-
localizations PML/Telomeres were evaluated by ImmunoFISH experiments and expressed in 
the graphs as classes of frequency of the percentage of PML found associated with telomeric 
DNA, respect to the total number of PML spots in the cell, counted in 50 cells. The lower 
panel consists of the graph illustrating the statistical analysis of PML/telomeres co-
localizations and triple (γH2AX /telomeres/PML) co-localizations, represented as fold change 
and carried out in WI38 cells, on 50 cells per type. P value is based on a two- tailed Student’s 
t-test. 
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This last hypothesis could be supported by a recent work that 
shows a role for telomeric DNA in the formation of PML NBs (see 
introduction) (Brouwer et al., 2009). 
 
1.3. PML NBs are recruited to telomeres of senescent 
fibroblasts and stem cells. 
 
Each time a cell divides telomereic DNA shorten until it reaches 
a critical length and it becomes unable to maintain the proper 
shelterin macromolecular structure, thus unveiling single-strand 
DNA ends  that are recognized by DNA damage surveillance 
machinery. These events activate the pathways that lead the cell to 
die or enter senescence (see introduction). For this reason, normal 
cells in vitro can undergo a limited number of population 
doublings before entering replicative senescence. 
 
 
Figure 7a. PML NBs recruitment to dysfunctional telomeres in late passages of human 
fibroblasts. WI38 were stained for telomeric DNA (red), PML (blue) and γH2AX (green), following 
the ImmunoFISH protocol. A representative image reveals the localization of PML to damaged 
telomeres (telomeres occupied by γH2AX) in a late passage (WI38 p25) respect to an early passage 
(WI38 p7) of culture of human fibroblasts. Some co-localizations are shown in enlargements. 
 
The normal telomere attrition due to serial passages in vitro has 
been used as a physiological model of telomeric damage. WI38 
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normal fibroblasts have a finite lifetime of 50 (plus or minus 10) 
population doublings with a doubling time of 24 hours. We 
performed ImmunoFISH staining to analyze PML localization to 
telomeres in WI38 at early passage (p7) respect to WI38 at passage 
25, corresponding to about 32 population doublings. At this late 
passage, WI38 cells start to show senescent phenotype. The 
number of TIFs per cell  increases from 1,78 of the control early 
passage cells to 4,86 of the late passage cells (Fig. 7a and 7b).  
 
Figure 7b. PML NBs recruitment to dysfunctional telomeres in late passages of human 
fibroblasts. WI38 were stained for telomeric DNA (red), PML (blue) and γH2AX (green), as in 
figure 6a. The graph illustrates the statistical analysis of PML/telomeres co-localizations and triple 
(γH2AX /telomeres/PML) co- localizations represented as fold change, carried out on 50 cells per 
type. P value is based on a two-tailed Student’s t-test. 
 
Statistic analysis on fifty cells revealed that PML NBs increase 
in number (data not shown) and are associated with telomeres at 
higher percentage in late passages respect to early passages. PML 
NBs are mainly recruited to telomeres associated with DNA-
damage foci. 
Similar results were obtained performing experiments on 
another normal diploid fibroblasts cell line, MRC-5 (data not 
shown). 
These results demonstrate that PML is involved in the response 
of the cell to telomere attrition caused by prolonged culture of cells 
in vitro.  
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Aging is associated with reduction of stem cells function. The 
molecular mechanisms of stem cells aging seem to involve 
telomere dysfunction that leads to induction of cell cycle 
checkpoints. Although most stem cell compartments express 
telomerase, the level of telomerase activity is not sufficient to 
maintain telomere length of stem cells during aging. Stem cells 
appear to have tighter DNA damage checkpoint control in 
comparison to somatic cells, which may reflect the need to protect 
this long lasting cell compartment against malignant 
transformation (Ju and Rudolph, 2006).  
PML is also involved in telomere-associated DNA damage 
response in aged stem cells? To address the issue we performed 
experiments on early and late passages of amniotic fluid-derived 
stem cells. These cells were isolated from amniotic fluid as 
previously described (Orciani et al., 2008), characterized for stem 
cells markers in the laboratory of Prof. Donti, and kindly provided. 
An early (p5) and a late (p18) passage of amniotic stem cells were 
compared for the number of co-localizations between PML NBs 
and telomeres, by ImmunoFISH performed with a PNA probe for 
telomeric DNA and an antibody directed against PML protein, as 
previously done in WI38 experiments. The number of PML spots 
associated with telomeres increases significantly in the late passage 
of amniotic stem cells, which show SA-β-galactosidase (SA-β-gal) 
activity, a classical marker of cellular senescence (data not shown).  
Telomeres co-localizing with PML NBs augment in response to 
a telomere attrition generated by prolonged culture of primary cells 
or stem cells in vitro, evidencing that the presence of PML is 
required not only by a generalized condition of telomere damage, 
but also by a physiological type of damage. The association of 
PML with damaged telomeres, generated by telomere shortening 
that occurs after several rounds of replication, underlines the 
involvement of the protein in mechanisms of cellular aging. 
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Figure 7. PML NBs recruitment to telomeres in late passages of amniotic fluid-derived stem 
cells. Amniotic stem cells were stained for telomeric DNA (red), PML (blue) and γH2AX (green), 
following the ImmunoFISH protocol. A representative image reveals the increase of localizations of 
PML to telomeres in a late passage (p18) respect to an early passage (p5) of culture of amniotic stem 
cells. Some co-localizations are shown in enlargements. The lower graph illustrates the statistical 
analysis of PML/telomeres co- localizations. The statistic was carried out on 50 cells per type 
(amniotic stem cells at passage 5 versus the same cells at passage 18). P value is based on a two-
tailed Student’s t-test. 
 
PML could take part in the repair of dysfunctional telomeres or 
in the signaling towards checkpoints that lead the aged cell to 
undergo cell cycle arrest or senescence. This role is essential 
because allows to avoid that cells continue to divide beyond their 
normal replicative limit and enter a stage of “crisis”. Crisis is 
marked by massive genomic instability, which is the major step 
towards oncogenic transformation. 
The data presented in this chapter demonstrate that PML is 
present at telomeres to mediate a DNA damage response. These 
observations prompted us to elucidate whether PML is actively 
involved in telomeres repair, maintaining telomere stability and 
preventing aging, or alternatively if it is involved in signaling of 
unrepaired telomeres towards cell cycle arrest, preventing cancer. 
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2. PML depletion  induces growth inhibition 
 
2.1. PML knockdown leads to premature senescence in 
normal fibroblast cell lines. 
 
In order to study the effects of PML on cellular growth and 
telomeres stability, we used the same lentiviral system discussed in 
paragraph 1.2 to stably deplete TRF2 expression, but in these case 
the shRNA were designed to target PML mRNA. 
Different oligos coding for shRNAs have been designed, and 
two of them have been chosen for their efficiency and used to 
perform all experiments. These two oligos target a region of PML 
within the exon 3, common to all PML isoforms. Hereafetr we will 
refer to them as PML Knock Down 1 and 2 (PML KD1 and PML 
KD2). As control we used a lentiviral vector coding a shRNA 
directed against a region of the gene luciferase, which is not 
present in mammals (pSicoR Luc). Downregulation of PML was 
checked by indirect immunofluorescence and western blotting 
analysis (Fig.9). The number of PML NBs and the protein levels of 
PML were strongly down-regulated by both PML KD1 and PML 
KD2, with the best efficiency for PML KD1. To test the stability of 
lentivirus-induced RNAi, we monitored the expression of PML in 
cells infected with PML KD1 and KD2 for two weeks after the end 
of the selection with puromycin. Over this period, cells showed no 
rise of the protein level (Fig.9). 
We used this suitable system to study the effects of PML on the 
cellular growth of normal and tumor cell lines, performing each 
experiment at least with the two oligos tested (PML KD1 and PML 
KD2) to reject the hypothesis of off-target shRNA effects. We 
knocked down PML in two normal fibroblast cell lines, WI38 and 
MRC-5, and we observed that PML depleted cells have a 
remarkable reduced growth rate, as revealed by the growth curves 
performed with the two independent PML shRNAs (PML KD1 and 
PML KD2) (Fig.10a). 
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Figure 9. Efficiency of PML RNAi-mediated knock down in U2OS cells. a) Indirect 
immunofluorescence with an anti-PML antibody shows PML NBs disappearance in cells infected 
with two independent shRNA for PML (PML KD1 and PML KD2) respect to control cells (infected 
with pSR Luc). b) Western Blot analysis shows that the PML protein levels are stably reduced by 
RNAi with PML KD1 for 20 days. 
 
WI38 and MRC-5 PML knock down (PML KD) cells undergo 
premature senescence before control cells. Senescence is showed 
by the morphological changes in cells shape that become flattened, 
vacuolated and enlarged. In addition PML knocked down cells 
show increased levels of SA-β-galactosidase staining. This assay is 
a good tool to detect senescent cells between an eterogeneous 
population as showed for the first time in 1995 (Dimri et al., 1995). 
Another feature of senescent cells are the Senescence 
Associated Heterochromatin Foci (SAHF), heterochromatin 
structures responsible for E2F target genes repression, usually 
enriched for histone H3 methylated on lysine 9 (meH3K9) (Narita 
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et al., 2003). Fibroblasts deleted for PML present a more 
distinctive localization of meH3K9 than the control cells, 
consistent with its concentration in the DNA foci of senescent cells 
(Fig.10c). 
 
 
 
 
Figure 10. PML knock down in human fibroblasts leads to premature senescence. a) Growth 
curves of human fibroblasts infected with two different PML shRNAs or a control shRNA (pSR 
Luc). Cells were counted in the indicated days after selection. Curves are representative of three 
independent experiments. b) SA-β-gal-staining performed on WI38 cells, 6 days post selection. c) 
Indirect immunoflorescence with an antibody specific for 3meH3K9 modification shows 
accumulation of the modified histone in foci, typical of senescent cells. 
 
The pathways activated during senescence in fibroblasts, 
involve the up- regulation of p53 and its target p21, and/or 
induction of p16 and ipo- phosphorilation of Rb (see introduction, 
paragraph 2.1.3). To investigate the pathways involved in 
premature senescence induced by PML depletion, western blot 
analysis has been performed on cellular lysates at different days 
after the end of selection with puromycin of infected cells. Up-
regolation of the cell cycle regulators p53, p21 and p16 was 
detected (Fig.11) and it was maintained for up than ten days, both 
in WI38 and MRC-5 fibroblasts. 
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Figure 11. PML knock down in human fibroblasts activates p53/p21 and p16/Rb pathways to 
induce premature senescence. Western Blotting showing up-regulation of p53, p21 and p16 protein 
levels in WI38 cells after 6 days of PML RNAi with two constructs for silencing (PML KD1 and 
PML KD2). 
 
In conclusion, PML knock down causes in human fibroblasts a 
growth inhibition that has the appearance of premature senescence, 
as demonstrated by positive SA-β-gal staining at pH6, presence of 
heterochromatin markers, like tri-metyl-H3K9, and activation of 
the typical pathways. 
 
 
2.2. PML knockdown induces growth inhibition in 
ALT-positive tumour cells. 
 
We extended the analysis of the effects of PML loss on cellular 
growth to ALT- positive tumour cells. 
Two ALT-positive cell lines, U2OS and SK-LU-1, that do not 
express telomerase, have been infected with lentiviral particles, 
expressing shRNAs targeting PML (PML KD1 and PML KD2), or 
the control vector (pSR Luc), as described above. PML depletion 
was checked by immunofluorescence and western blotting. At the 
end of selection, 3x103 cells were seeded in a 6 well plate and 
counted at the indicated days. Growth curves show a significant 
reduction of growth rate for PML knock down cells, respect to 
control cells (Fig.12). 
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Figure 12. PML knock down causes reduction of growth rate in ALT-positive tumour cells. 
Growth curves of U2OS and SK-LU1 ALT cells, infected with two different PML shRNAs or a 
control shRNA (pSR Luc). Cells were counted in the indicated days after selection. The curve 
reported for each cell types is representative of three independent experiments. 
 
To obtain an independent confirmation of the decreased growth 
potential of cell lacking PML, we performed a colony formation 
assay, which measures the clonogenic ability of a cell to divide and 
produce a colony when plated at low density. 
Cells infected with the three different viruses, were plated, after 
the end of selection with puromycin, at a density of 500 cells in a 6 
cm tissue culture dish, in triplicate. After two weeks in culture, 
colonies were stained and counted to evaluate the colonies number. 
Alternatively, colonies were counted at the microscopy, than 
trypsinized to count the total number of cells on the plate. The 
number of cells divided for the number of colonies gives us the 
mean value of cells for colony, which represents a measure of 
colonies size.  
ALT cells in which PML is silenced have a reduced capacity to 
form colonies, evidenced by a lower number and a smaller size of 
formed colonies, respect to control cells infected with an irrelevant 
shRNA (Fig.13). Interestingly, the biological effect on cellular 
growth seems to be dose-dependent, because it is more pronounced 
for the PML KD1 construct that have stronger effect on PML 
protein levels than PML KD2. This observation allows us rejecting 
the objection of an off-target effect. 
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Figure 13. Decreased colonies formation in PML knock down ALT-positive tumour cells. a) 
Representative clonogenic assay showing decreased colony formation in PML KD1 and KD2 ALT 
cells compared with cells infected with the control vector (pSRLuc). b) Photos showing the different 
sizes of single colonies of U2OS treated with the indicated vectors. c) Quantification of the colony 
formation assay. Graphs of colonies number represent the percentage of colonies respect to the 
control assumed as 100%. Histograms represent the mean and error bars the s.d. of three independent 
experiments; in each of them samples were plated in triplicate. Graphs of colonies size represent the 
number of cells/colony expresses as percentage respect to the control assumed as 100%. Histograms 
represent the mean and error bars the s.d. of three independent experiments; in each of them samples 
were plated in triplicate. The differences are statistically significant, as shown by the asterisks.  
(*** = P<0,001, ** = P<0,01, * = P<0,05, according to a two-tailed Student t-test). 
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To elucidate the pathways activated by down-regulation of 
PML, cellular lysates obtained at different days after stable 
interference were analyzed by western blotting to detect the levels 
of the major cell cycle regulators. We observed increase of p53 and 
p21 protein levels in U2OS cells (Fig.14), just after the end of the 
selection and for more than ten days (data not shown). 
Osteosarcoma U2OS cells do not express p16 protein due to 
hypermethylation of the INK4/ARF locus, so we analyzed the 
levels of another cyclin-dependent kinase inhibitor involved in the 
control of cell cycle G1 progression, p15. p15 is up-regulated in 
U2OS cells lacking PML (Fig.14). 
 . 
Figure 14. Pathways involved in cell cycle arrest induced by PML knock down in ALT tumour 
cells. Western Blotting showing up-regulation of p53, p21 and p15 protein levels in U2OS cells, and 
hypophosphorylation of pRb in SK-LU1 cells, after 6 days of PML RNAi with two constructs for 
silencing (PML KD1 and PML KD2). 
 
SK-LU-1 is a lung adenocarcinoma cell line with a mutation of 
p53 that is expressed but not functional and not regulated. They do 
not express p16 and p15 due to homozygous deletion of the 
p16INK4 and p15INK4B genoomic locus. On the other hand, SK-LU-1 
cells express the Retinoblastoma protein (pRb), a cell cycle 
inhibitor. In the hypophosphorylated state, pRb is active and 
carries out its role as tumor suppressor by inhibiting cell cycle 
progression. Phosphorylation by cyclin- dependent kinases (CDK) 
and cyclins inactivates pRb. We noticed a slight reduction of 
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phosphorilated Rb levels, according to the possible role of pRb in 
inhibition of proliferation induced by PML depletion. 
Therefore, PML knock down reduces proliferation of ALT 
tumour cells, as evidenced by growth curves and colony formation 
assay. This event could involve p53/p21 and/or pRb pathways. 
Differently from normal fibroblasts, ALT cells do not undergo 
senescence, even after long time of PML depletion, as evidenced 
by negativity to SA-β-gal staining performed until two months of 
interference. The magnitude of the effect seems correlated with the 
efficiency of PML knockdown, and this could be dependent from 
the reduction of the association of PML NBs from telomeres. 
 
 
2.3. PML knockdown induces only a slight growth 
inhibition in telomerase-positive tumour cells. 
 
Analogously to ALT cells, we performed assays to reveal the 
effect of PML depletion on tumour cells expressing telomerase. 
For this study we used HeLa cells, a cervical cancer cell line 
which do not express p53 protein, and A549 cells, a lung 
carcinoma cell lines, positive for p53 but negative for p16 and p14 
expression. 
Growth curves reveal no effect of PML RNA interference in 
HeLa cells, while show a slight growth inhibition in A549 (Fig.15). 
 
Figure 15. PML knock down in telomerase-positive tumour cells induces only a slight 
reduction of growth rate. Growth curves of HeLa and A549 cells, infected with two different PML 
shRNAs or a control shRNA (pSR Luc). Cells were counted in the indicated days after selection. 
The curve reported for each cell types is representative of three independent experiments. 
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Colony formation assay displays that no difference in the 
number of colonies arises after PML silencing. However, a little 
decrease of size appears especially in A549 cells depleted of PML 
protein (Fig.16). 
Key cell cycle regulators such as p53, p21, p16 and p15 show 
no substantial protein levels modification (data not shown).  
 
Figure 16. Irrelevant effect of PML knock down in telomerase-positive tumour cells on 
colonies formation capacity. a) Representative clonogenic assay showing only a small reduction of 
the size of colonies, but no differences in the number of formed colonies, in PML KD1 and KD2 
cells compared with cells infected with the control vector (pSR Luc). b) Quantification of the colony 
formation assay. Graphs of colonies number represent the percentage of colonies respect to the 
control assumed as 100%. Histograms represent the mean and error bars the s.d. of three independent 
experiments, in each of them samples ware plated in triplicate. Graphs of colonies size represent the 
number of cells/colony expresses as percentage respect to the control assumed as 100%. Histograms 
represent the mean and error bars the s.d. of three independent experiments; in each experiment 
samples were plated in triplicate. The differences in the colonies number are not statistically 
significant (n.s.), while small significant differences are present in colonies size, as shown by the 
asterisks. (** means P<0,01, * means P<0,05, according to a two-tailed Student t-test). 
 
 
In conclusion, HeLa and A549 are less affectd by PML loss-
dependent growth inhibition than the other types of cells 
previously analyzed. These data on telomerase-positive tumor cell 
lines are not completely understood. We could hypothesize that 
PML effects on proliferation are less evident in telomerase-positive 
cells. A telomerase-inhibited effect of PML knock down could 
support the idea that PML loss causes a cell cycle arrest due to its 
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failed role on telomere maintenance. PML effect could be hidden 
by telomerase, because this protein could compete with PML for 
telomeres maintenance. Moreover, it has been recently showed that 
PML is a negative regulator of Telomerase activity, and the two 
proteins directly interact (Oh et al., 2009). PML role in telomere 
maintaince could be masked by Telomerase activity, altought this 
is in contrast with the work by Oh and colleagues. On the other 
hand, p53 role could be foundamental for PML suppression growth 
inhinition. This could be an explanation for irrelevant effects 
observed in HeLa cells, negative for p53, compared with the 
moderate but not undetectable growth inhibition in A549 cell line. 
Definitively, supplementary experiments are in progress and they 
will shed light on this unsolved issues. 
 
 
 
3. PML deficiency induces telomere 
dysfunctions. 
 
 
Replicative cellular senescence can be initiated from 
dysfunctional telomeres, which are recognized by DNA damage 
response factors and are detected as Telomere dysfunction-Induced 
Foci (TIFs) (see introduction, paragraph 2.1.3). 
We just showed that PML localize to telomeres in all cell types 
and PML depletion in normal and ALT cells results in severe 
growth inhibition. This two events can be linked creating the 
hypotesis that PML depletion cause telomere dysfunctions. 
To demonstrate this assertion we analyzed PML knock down 
cells for the presence of TIFs. First of all we performed this 
analysis on human normal fibroblasts that enter senescence when 
PML is loss, as showed above. WI38 and MRC-5 cells were 
infected with PML KD1 vector or with the control vector (pSR 
Luc), selected for four days with puromycin and plated on 
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coverslips. After fixing them, cells were stained following the 
ImmunoFISH protocol, with a fluorescent labeled PNA probe 
specific for telomeric repeats, and an antibody directed to γ-H2AX. 
TIFs, revealed as foci of γ-H2AX associated with telomeres, were 
analyzed with confocal microscopy (Fig.19) and counted in fifty 
cells per sample.  
 
 
 
Figure 17. Increased telomere dysfunction in PML knock down MRC-5 cells. Top: MRC-5 cells 
were efficiently treated for PML interfering, as shown by the disappearance of PML NBs. TIFs, 
detected by co- localization of γ-H2AX and telomeres, increase in PML knock down cells. 
Representative images acquired at confocal microscope are shown. Bottom: Graph representing the 
mean percentage of cells with more or equal than three TIFs per cell. Analysis was performed 
counting TIFs in fifty cells per sample, in MRC-5 and WI38 normal fibroblasts. 
 
PML knock down cells data shows that the number of telomeres 
co-localizing with DNA-damage response factors foci substantially 
increases (Fig.18), and there is an enlargement of population of 
cells with dysfunctional telomeres (Fig.17). We extended the 
analysis to tumour cell lines used in the previous experiments, to 
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determine if the effect of telomere damage is generally caused by 
PML loss, independently by the cell system. 
 
 
 
Figure 18. Increased telomere dysfunction in all types of PML knock down cells. WI38, MRC-5, 
U2OS and Hela cells were efficiently treated for PML interfering. ImmunoFISH using a florescent 
PNA probe for telomeric repeats and an antibody specific for γ-H2AX was performed. TIFs were 
detected by co- localization of γ-H2AX and telomeres. Histograms represent the mean of TIFs/cell. 
Analysis was performed counting TIFs in fifty cells per sample. Significant differences are 
evidenced by asterisks (*** means P<0,0001, ** means P<0,01, * means P<0,05, according to a 
two-tailed Student t-test). 
 
The results indicate that PML contributes to telomere stability 
in U2OS ALT-positive cells, because its depletion results in 
significant increase of TIFs. Therefore PML knock down can cause 
telomere dysfunction also in tumour cells. 
Telomerase-positive HeLa cells seem to undergo only a modest 
telomere damage as result of PML depletion, and they present only 
a limited increment of TIFs. These data are in agreement with the 
previous experiment in which HeLa cells react to PML loss with a 
barely perceptible inhibition of growth, evidenced only in a modest 
reduction of colonies size in cells infected with the construct PML 
KD1, more efficient for PML silencing. This result could support 
our hypothesis that PML and telomerase both participate to 
telomeres maintenance. However, telomerase may be sufficient to 
stabilize telomeres also when PML is absent, thus hiding the role 
of PML. 
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Summarizing, the experiments have identified a crucial role for 
PML in telomere stability. PML knock down leads in fact to 
accumulation of telomere dysfunctions, determined by the increase 
of TIFs. The mechanism at the basis of this event it is not 
completely understood, but maybe PML loss could destabilize 
telomere structure or more probably could impair the normal repair 
of damaged telomeres. The final effect is a transduction of damage 
signals towards the activation of checkpoints. Both p53/p21 and/or 
pRb/p16 pathways seem activated in cells lacking PML, with 
differences depending on the cell type. Increased levels of cell 
cycle inhibitors lead cells to growth rate reduction that even 
appears as premature senescence in normal primary cells. 
PML role has always been associated with tumor suppression 
mechanisms and its overexpression causes reduction of 
proliferation by induction of apoptosis and senescence (see 
introduction, paragraph 3.3). The results we obtained in this work 
seem to be in contrast with this knowledge, because we show that 
also PML depletion leads to growth inhibition, reducing even the 
proliferation of cancer cells. These data rather underline a role for 
PML as an oncogene. 
PML could play a double role, as tumour suppressor or 
oncogene, depending on the contest, as two face of the same 
medal. On one hand, PML act as a “guardian” of telomeres 
stabilizing and allowing normal growth and preventig the arise of 
genomic instability, but on the other hand, this should be balanced 
with its role in p53-mediated senescence. 
In support to our findings of a potential role of PML as 
oncogene, a recent work of Ito and colleagues defines the critical 
function of PML in haematopoietic stem cell maintenance, in 
particular of quiescent leukaemia-initiating cells and suggest a new 
therapeutic approach for targeting possibly cancer-initiating cells 
by pharmacological inhibition of PML (Ito et al., 2008). 
In conclusion, in cancer condition, it could be useful to inhibit 
the oncogenic function of PML to reduce tumour progression, but 
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in normal condition PML, stabilizing chromosome end, could have 
a role in preventing aging and cancer transformation. 
 
 
 
 
 
 
4. PML association with phospho-DNA-PKcs in 
telomere damage response 
 
 
The group in which I developed the PhD project, was one of the 
first to clone the translocation t(15;17) and successively four of the 
seven known PML isoforms (Jensen et al., 2001). An antibody able 
to visualize the characteristic nuclear domains in which PML 
accumulates was also generated. These structures, which may 
recruit a host of proteins, have been associated with many 
functions such as transcription regulation, genome stability (DNA 
repair, senescence and telomere maintenance), viral infection, 
apotosis and tumor suppression. However, the function of PML 
and PML-NBs is still unclear. To understand the molecular basis of 
the PML function, the proteins that physically interact with PML 
have been isolated in vivo by immunoprecipitation of the 
endogenous PML complex in 293T cells. The PMLIV isoform, 
tagged to Flag epitope, was over-expressed to a very low level to 
obtain a size and number of nuclear bodies comparable to 
endogenous pattern. The co-precipitated proteins were analyzed by 
mass spectrometry originating a list of the PML interacting 
proteins: it has been found structural proteins  (α e β-actin,…), 
proteins of the metabolism [Ribosomal Protein L4 (RPL4), 
RPL5,...] and a wide range of proteins involved in the transcription 
and modification of RNA [heterogeneous nuclear 
RiboNuclearProtein G (hn RNP G), hn RNP M, ADAR1...], casein 
Dottorato di ricerca in Genetica e Biologia Molecolare 
 Pag. 97  
kinase 2 (CK2), and proteins involved in the DNA-damage 
response (Mre11, RAD50 and DNA-PKcs) (Fig.19). 
Because of its known function in telomere maintenance, we 
focused our attention on DNA-PKcs and decided to validate its 
interaction with PML. This was a likely candidate to explain the 
mechanisms at the basis of PML function in telomere metabolism.  
DNA-PKcs is a member of phosphoinositide-3-kinase-related 
(PIKK) family, which associates with the Ku70/80 heterodimer to 
form the catalytically active DNA-PK holoenzyme, one of the 
main components of Non Homologous End-Joining (NHEJ) 
pathway (see introduction, paragraph 2.1.1), the predominant 
mechanism of DSB repair. DNA-PKcs associates with telomeric 
DNA in human cells, and several works reported its role in 
telomere protection. Inhibition of DNA-PKcs catalytic activity 
results in telomere shortening, fusions and genomic instability 
(Bailey et al., 2004; d'Adda di Fagagna et al., 2001; Ruis et al., 
2008). 
 
 
 
 
 
Figure 19. PML complex isolation. On the left, scheme of the passages of the procedure performed 
to isolate the high molecular complex of PML. On the right, short list of proteins found associated 
with PML. 
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4.1. Phospho-DNA-PKcs localizes with PML at 
telomeres of ALT cells.  
 
 
ALT cells present a novel class of PML NBs, known as APBs, 
which contain telomeric DNA and protein involved in DNA 
recombination, replication and repair. 
The results of PML macromolecular complex suggest the 
interaction of PML with DNA-PKcs, an important factor involved 
in DNA repair and telomere stability. For this reason we decided to 
start imaging experiments to investigate an hypothetical interaction 
in the APB of ALT cells. Interestingly, we noticed by 
immunofluorescence that PML co-localizes with DNA- PKcs 
phosphorylated at Thr2609 in U2OS (Fig.20). 
Thr2609 is a key regulation site of DNA–PK activity. In 
response to DNA damage as, for example, ionizing radiation, 
DNA-PK complex is activated and phosphorylates its targets, 
among them the subunit DNA-PKcs itself (see introduction, 
paragraph 2.1.1) (Douglas et al., 2002). Autophosphorylation of 
Thr 2609 is a Ku-dependent event, important for NHEJ, because 
mutation of this site impairs DSB rejoining (Ding et al., 2003). 
Mutant DNA-PKcs protein for residue Thr2609 maintains the 
protein kinase activity but it is defected for its ability to support 
ligation of DNA ends (Block et al., 2004b). DNA-PKcs 
phosphorylated on Thr 2609 co-localizes with γ-H2AX and 53BP1 
at the sites of DNA DSBs (Chan et al., 2002). Performing 
immunoFISH analysis, using a fluorescent-labeled PNA probe for 
telomeric repeats concomitantly with an antibody directed towards 
PML and an antibody that specifically recognizes the 
phosphorylated form of DNA-PKcs at Thr2609, we could observe 
that PML and phospho-DNA-PKcs co-localize at telomeres of two 
analyzed ALT cell lines, U2OS and SK-LU-1. 
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Figure 20. PML co-localizes with phospho-DNA-PKcs at telomeres of ALT cells. U2OS and SK-
LU1 ALT cells were stained for DNA-PKcs phosphorylated at Thr2609 (green), telomeric DNA 
(red) and PML (blue), following the ImmunoFISH protocol. Confocal microscopy revealed the 
perfect co-localization of the two proteins at telomeres, as large white spots, in both the two cell 
lines. 
 
The co-localization between the two proteins takes place in 
particular in large PML NBs, which correspond in ALT cells to 
APBs, and that associate with foci of telomeric DNA larger than 
signals from individual telomeres (Yeager et al., 1999) (see 
introduction, paragraph 1.4.2) (Fig.20). Statistic analysis of 
visualized co-localizations was performed on fifty cells per sample. 
The interesting data emerging from this experiment is that PML 
and phospho-DNA-PKcs associate specifically at telomeres. The 
graphs in figure 21 show that, even if some spots of PML could 
localize at telomeres without phospho-DNA-PKcs, all spots of 
phospho-DNA-PKcs co-localizing with PML are localized at 
telomeres. In fact, the histogram representing the mean number of 
PML/phospho-DNA- PKcs co-localizations and the histogram of 
the triple co-localizations with telomeres are comparable, while the 
histogram of PML/telomeres co-localizations is higher than the 
triple’s one (Fig.21, top) in both cell lines. 
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Figure 21. PML association with DNA-PKcs takes part at telomeres. Top: Graphs representing 
the mean values of spots for cell. Analysis was performed on 50 cells per sample. Bottom: 
Distributions of population show the percentage of cells that presents a certain percentage of 
phospho-DNA-PKcs co- localizing with PML (blue line), Telomeres (dark pink line) or both (green 
line). 
 
In agreement, observing the graphs (Fig.21, bottom) 
representing the subpopulations of cells which have a certain 
percentage of phospho-DNA-PKcs co-localizing with PML (blue 
line), with telomeres (dark pink) or both (green), we can appreciate 
that the blue and the green curves are quite overlapping, indicating 
that all phospho-DNA-Pkcs associated with PML is also associated 
with telomeres. Vice versa, almost all phospho-DNA-PKcs spots 
present at telomeres are co-localizating with PML NBs, even if in 
U2OS there are some signlas of the phospho-DNA-PKcs present at 
telomeres independently from the presence of PML (Fig.21, 
bottom). In other words, the association between PML and DNA-
PK arise at telomeres. 
These immunofluorescence experiments not only support the 
interaction between PML and phospho-DNA-PKcs, noticed by the 
isolation of the PML complex, but also identified phospho-DNA-
PKcs as a novel component of APBs. 
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Moreover, considering these data it is likely that PML could be 
necessary to the association of phospho-DNA-PKcs with telomere. 
However, some spots of phospho-DNA-PKcs seem to be 
localized at telomeres in absence of PML in U2OS cell line. This 
could reflect a simple tecnical problem in detecting PML at those 
telomeres, or that PML is necessary for the initial association of 
phospho-DNA-PK or for its autophosphorylation at telomeres and 
it could then leave the DNA-PK/telomeres/PML tri-complex. 
Nevertheless, additional experiments are necessary to evaluate 
the possibility that a quota of phospho-DNA-PKcs can associate to 
telomere in a PML- independent manner. 
 
 
4.2. PML knock down destabilizes phospho-DNA-PKcs 
from telomeres. 
 
In view of these results, we investigated if PML is responsible 
for the localization of DNA-PKcs phosphorylated at Thr2609 at 
telomeres. 
To elucidate this purpose, we performed RNA interference for 
PML in two different ALT cell lines, U2OS and SK-LU-1, and 
analyzed the co-localization between the phosphorylated DNA-
PKcs and telomeric DNA. 
RNAi interference was performed as described above, using the 
PML KD1, that has the strongest effect on PML down-regulation, 
and the control vector pSR Luc. Cells were stained following the 
usual ImmunoFISH protocol (Fig.22). Counting fifty cells per 
sample, it was evident a reduction of phospho-DNA-PKcs 
association at telomeres (Fig.23). SK-LU-1 cells, expressing very 
high levels of PML, were silenced following the adapted protocol 
that consists of two sequential series of infections. The low 
significance of the result obtained in SK- LU-1 could however 
reflect the incomplete knock down of PML. 
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Figure 22. PML knock down destabilizes DNA-PKcs from telomeres of ALT cells. U2OS and 
SK-LU1 ALT cells were infected with control vector (pSR Luc) or with a vector for PML 
interference (PML KD). Six days after the end of selection in puromycin, cells were stained for 
DNA-PKcs phosphorylated at Thr2609 (green), telomeric DNA (red) and PML (blue), following the 
ImmunoFISH protocol. Confocal microscopy revealed the loss of co-localization of phospho-DNA-
PKcs and telomeres, after PML depletion. 
 
The graph in figure 23b underlines a shift of U2OS cells lacking 
PML towards populations presenting a low percentage of phospho-
DNA-PKcs localized at telomeres. However, it seems that not all 
the singnals of phospho-DNA-PKcs are delocalized from the 
telomeres after PML interference. This could happens for two 
reasons: an incomplete PML depletion or a quota of phospho-
DNA-PKcs is associated at chromosome ends independently from 
PML. 
In conclusion, PML is necessary to maintain at least a portion of 
the interactions between phospho-DNA-PKcs and telomeres.  
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Figure 23. Interaction of phospho-DNA-PKcs with telomeres is impaired by PML loss. a) 
Graphs representing the mean values of spots per cell. Analysis was performed on 50 cells per 
sample. P value was calculated according to Student t-test. b) Distribution of cellular population 
show the percentage of cells that presents a certain percentage of phospho-DNA-PKcs co-localizing 
with telomeres, in PML KD cells (broken line) versus control cells (unbroken line) . 
 
 
4.3. PML physically interacts with DNA-Pkcs and with 
its phosporylated form 
 
 
The isolation of molecular complex of PML gave the 
preliminary  results of the interaction beetwen PML amd DNA-PK. 
These were confirmed by immunofluorescence, but a robust 
biochemical data was still missing.  
Thus we performed co-Immunoprecipitation experiments in 
U2OS cells. 
Nuclear extracts of cells immunoprecipitated with an anti-DNA-
PKcs antibody, revealed a complex with endogenous PML. 
Western blot analysis with an antibody against PML that 
recognizes all isoforms, shows two bands that migrate at the 
molecular weight corresponding to PML I and PML IV (Fig. 24a). 
In agreement, nuclear extracts of U2OS immunoprecipitated with 
the PML antibody, contained DNA-PKcs (Fig. 24b). We also 
investigated whether PML interacts with DNA-PKcs 
phosphorylated at Thr 2609 using an antibody targeting this 
specific post-translational modification. As shown in Fig.24b, there 
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is a weak but detectable interaction between endogenous PML and 
the phosphorylated form of DNA-PKcs. 
 
Figure 24. Endogenous PML interacts with DNA-PKcs and its phosphorylated form. a) Nuclear 
extracts from U2OS cells were immunoprecipitated with an anti-DNA-PKcs antibody. Wester 
blotting was performed with anti-PML and anti-DNA-PKcs antibodies, as indicated. b) The same 
nuclear extrats as in a) were immunoprecipitated with anti-PML or anti-DNA-PKcs phosphorylated 
(Thr2609). Wester blotting was performed with anti-DNA-PKcs and anti-PML antibodies to show 
the reciprocal interaction. Nuclear lysates were loaded as a control (input). 
 
Therefore, we demonstrated that PML forms a stable complex 
with DNA-PKcs, an important component of DSB repair. We also 
show that PML interacts with DNA- PKcs phosphorylated at 
Thr2609, an activated form of the protein required for NHEJ, in 
ALT cells. 
 
 
4.4. Specific telomere damage increases the amount of 
PML – DNA- PKcs complex. 
 
 
The localization of PML–phospho-DNA-PKcs complex at 
telomeres in ALT cells suggests a possible role of this association 
in telomere stability. 
In the experiments presented before we demonstrated that PML 
is recruited to dysfunctional telomeres. To study whether telomere 
damage has an effect on the association between PML and 
phosphorylated DNA-PKcs, we analyzed the complex formed by 
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the two proteins biochemically, after treatment with RHPS4. This 
drug leads to TIFs formation and increases PML localization to 
dysfunctional telomeres, if used at a concentration of 1µM for 24h 
(see paragraph 2.1.3 of the introduction and paragraph 1.2 of this 
section). 
We used the same treatment to induce telomere damage in 
U2OS cells, and we performed immunoprecipitation assay with an 
anti-PML antibody and with the antibody recognizing the 
phosphorylated form of DNA-PKcs at Thr2609 (Fig.25). 
 
 
 
Figure 25. Interaction of DNA-PKcs with PML is increased by telomere damage. Nuclear 
extracts from U2OS cells, treated (+) or untreated (-) withRHPS4, were immunoprecipitated with 
anti-PML antibody or with anti-DNA-PKcs-phosphorylated at Thr2609 antibody. Wester blotting 
was performed with anti-PML and anti-DNA-PKcs antibodies, as indicated. An immunoprecitation 
with IgG was performed as negative control. Input represents nuclear lysates. 
 
Inputs reveal no differences in total levels of DNA-PKcs. 
However the antibody directed towards the phosphorylated form, 
immunoprecipitated a higher quantity of the protein after telomere 
damage, revealing that under this condition DNA-PKcs can 
undergo autophosphorylation. As shown before by 
immunofluorescence, PML protein increases moderately after 
treatment with RHPS4. PML immunoprecipitated contained more 
DNA-PKcs after telomere damage, demonstrating that the 
stechiometry of the complex was increased. Western blotting anti-
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PML on immunoprecipitated by anti-phospho-DNA-PKcs 
(undetectable at basal levels, but significantly increased after 
treatment) demonstrated that the treatment enhances the 
association of this phopshorylated form with PML (Fig.25). In 
conclusion, a specific damage directed against telomeres, not only 
increases the localization of PML to the chromosome ends, but 
also leads DNA-PKcs, particularly in its phosphorylated form, to 
associate with PML. It is possible that PML localized at damage 
telomeres could recruits proteins involved in recombination and 
repair, as DNA-PKcs, and regulates their activity. 
APBs could represent site of repair for damaged telomeres, 
present at steady state in ALT cells, where phospho-DNA-PKcs is 
recruited by PML. 
 
 
4.5. Phospho-DNA-PKcs localization at PML NBs 
increases in normal cells after telomere-damage 
 
 
To investigate if PML co-localization with DNA-PKcs 
phosphorylated at Thr2609 is present also in non-ALT cells, and if 
the association of the two proteins in response to a telomeric 
damage could be a general mechanism, we extended experiments 
on telomerase-positive tumour cells and on normal cells. An 
extensively analysis by immunofluorescence revealed that at basal 
level, telomerase-positive HeLa and A549 cells, have very low 
abundance of phospho- DNA-PKcs (about 1-2 small spots per cell) 
and practically none of the spots associate with PML or telomeres 
(data not shown). 
Among an asyncronous population of interfase normal 
fibroblast cells, only some rare cells present spots corresponding to 
phospho- DNA-PKcs, and interestingly a certain number of them 
co-localizes with PML (Fig.26). To understand if this association 
could take part in response to telomere damage, we induced in two 
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types of fibroblasts, WI38 and MRC-5, the deprotection of 
telomeres by TRF2 knock down. 
After infections with lentiviruses particles and four days of 
selection in puromycin, we seeded the cells which were entering 
senescence on coverslips for immunofluorescence (Fig.27, Top). 
Indirect immunofluorescence with anti-PML and anti- phospho-
DNA-PKcs antibodies showed a high increase of cells positive for 
phospho-DNA-PKcs spots, which reach 100%, with a raised 
number of spots per cell (Fig.27, Bottom). TRF2 depletion also 
leads this protein to localize in PML NBs, as proved by the high 
number of PML/phospho-DNA-PKcs co-localizations. In 
summary, PML and DNA-PKcs physically interact. PML 
associates with the phosphorylated form of DNA-PKcs in APBs of 
ALT cells at basal conditions. This association increases after 
telomere damage in both ALT and normal primary cells. These 
findings suggest that PML-DNA-PKcs interaction has a role in 
response to telomere damage. 
Our data propose that the mechanism of association of damaged 
telomere to PML NBs and the consequent recruitment of proteins 
is not limited to ALT cells, but it could be a process common to 
diverse cellular types. ALT cells, maintaining their telomeres by 
recombination that lead to a constant presence of cells with 
telomeres reaching a short length, permit to observe, in a subset of 
cellular population, phenomena that occur in other cells only under 
conditions of telomere damage. Generating massive telomere 
damage allow to notice that also normal and telomerase-positive 
cells present PML NBs associated with telomeres, and activate 
autophosphorylation of DNA-PKcs. 
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Figure 26. PML co-localizes with phospho-DNA-PKcs in few normal fibroblasts. a) 
Immunofluorescence for DNA-PKcs phosphorylated at Thr2609 (green) and PML (red) shows a 
WI38 cell presenting co-localizations. b) An image obtained with confocal microscopy confirming 
the interaction.  
 
 
 
 
Figure 27. PML co-localization with phospho-DNA-PKcs in normal fibroblasts after telomeric 
damage. Top) Immunofluorescence for DNA-PKcs phosphorylated at Thr2609 (green) and PML 
(red) shows the increment of co-localizations between the two proteins in normal fibroblasts 
depleted forTRF2. Bottom) Graphs representing the mean values of spots per cell. Analysis was 
performed on 50 cells per sample, treated as in figure 30a. P value was calculated according to 
Student t-test. 
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Considering all the results, it is likely that PML could mediate 
the phosphorylation and recruitment of DNA-PKcs to telomeres in 
response to damage. This event could be important in telomere 
maintenance, and we could hypothesize that the accumulation of 
telomere damage in PML depleted cells is an effect of the 
destabilization of phospho-DNA-PKcs from telomeres. Ongoing 
experiments are ongoing to demonstrate this hypothesis. 
  
 
 
4.6. PML depletion leads to genomic instability. 
 
These interesting observations let a question arise: which are the 
molecular mechanisms that could link  the observed PML-
dependent growth inhibition with DNA-PK destabilization from 
telomeres?  
It is well established that DNA-PK deficiency results in 
anaphase bridges and genomic instability deriving from abnormal 
telomeric fusions (Goytisolo et al., 2001). Binucleated Cells (BNs) 
and Abnormal Nucleous Morphogenesis (AMNs) as 
Nucleoplasmic Bridges (NPBs), Micronuclei (MNs) and Nuclear 
Buds (Bs) are biomarker of genomic instability linked to telomeric 
defects (Pampalona et al., 2010). 
Given these considerations we addressed the issue of genomic 
instability in PML depleted human fibroblast MRC-5 cells.  
At first, we simply detected an important increase in binucleated 
cells stained with DAPI in our asyncronous interphase fibroblasts 
after PML RNAi  using phase contrast microscopy (Fig.28). 
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Figure 28. Percentage of binucleated cells in PML knock down MRC-5 cells. The graph shows 
percentages of binucleated cells in control RNAi and PML Knock Down RNAi (PML KD1) on total 
asyncronous population, evaluated by DAPI coloration. Number of binucleated cells were 
determined with phase contrast microscopy.  
 
Following these preliminary observations we performed an 
experiment using blebbistatin, a selective cell-permeable inhibitor 
of non-muscle myosin II ATPases, that induces binucleation 
through citokinesis inhibition (Straight et al., 2003). Using this 
drug we were able to block our cells after mitosis but before 
cytokinesis, in order to increase the probability of ANMs . We 
analyzed only binucleated cells in search of ANMs as markers of 
genomic instability, evaluating Nucleoplasmic Bridges (NPBs), 
Micronuclei (MNs) and Nuclear Buds (Bs) by DAPI coloration 
(Fig.29a). A consistent increase in overall ANMs was detected in 
PML deficient cells, and, in particular, nucleoplasmic bridges 
strongly increased respect to control cells (Fig.29b). 
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Figure 29. Percentage of ANMs in binucleated MRC-5 cells after PML knock down. a) The 
graph shows overall ANMs in PML depleted cells. Nucleoplasmic Bridges (NPBs), Micronuclei 
(MNs) and Nuclear Buds (Bs) were counted and percentages are calculated on total cells. b) The 
lower panel shows a dividing PML interfered cell with typical nucleoplasmic bridge. Dashed box 
shows an enlargement of original image. 
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These defective phenotypes are of great interest in our work, 
because it is known that they could be directly linked to telomere 
dysfunction through mechanisms dependent on DNA-PK catalytic 
activity, as mentioned above. These could confirm our hypothesis 
that PML ablation leads to DNA-PK phosphorylation defects, 
resulting in genomic instability  and impaired cell growth.  
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MATERIAL AND METHODS 
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Cell culture  
 
Primary cells and cell lines 
Normal human WI38 fibroblasts were maintained in Dulbecco’s 
Modified Eagle’s Medium (DMEM) supplemented with 10% 
North American Fetal Bovine Serum (FBS), penicillin (100 
units/ml) and streptomycin (100 µg/ml). Human fibroblasts BJ and 
their TERT-transfected clone (BJ-TERT)239, MRC-5 fibroblasts, 
and lung adenocarcinoma cell line SK-LU-1 were cultured in 
Eagle's Minimum Essential Medium (MEM) supplemented with 
10% North American FBS, penicillin (100 units/ml) and 
streptomycin (100 µg/ml), non-essential amino acids (0,1 mM) and 
sodium pyruvate (1 mM). 293T cells, cervix adenocarcinoma cell 
line HeLa, lung carcinoma cell line A549 and osteosarcoma cell 
line U2OS were maintained in DMEM supplemented with 10% 
FBS, penicillin (100 units/ml) and streptomycin (100 µg/ml). 
Osteosarcoma cell line Saos-2 was cultured in McCoy’s Medium 
supplemented with 15% FBS, penicillin (100 units/ml) and 
streptomycin (100 µg/ml). HTC75 cell line, kindly provided by T. 
De Lange19, was maintained in high glucose DMEM 
supplemented with 10% FBS, penicillin, streptomycin, and 100 
ng/ml doxycyclin. Amniotic fluid-derived stem cells were kindly 
provided by Donti E. All cells were cultured in 5% CO2 at 37°C. 
 
Mouse Embryonic Fibroblasts (MEFs) preparation 
MEFs were prepared from day 13.5 embryos derived from WT 
mice. The whole embryo was minced and dispersed in 10 cm plate 
in 1 ml trypsin then incubated at 37 °C for 10 minutes. 9 ml of 
DMEM plus 10% North American FBS, penicillin (100 units/ml) 
and streptomycin (100 µg/ml) were directly added to the minced 
embryo and incubated in 9% CO2 at 37 °C until confluence and 
splitted once. After that cells were used to perform experiments. 
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Calcium-phosphate transfection 
DNA was diluted in 439 µl of ddH2O and mixed with 61 µl of 2M 
CaCl2. The mixture was added, drop-wise, to 500 µl of 2x HBS 
(HEPES-Buffered Saline: 50 mM HEPES pH7.1, 280 mM NaCl, 
1.5 mM Na2HPO4, final pH7.1). After 15 minutes the precipitate 
was added to cells plated on a 10 cm dish and removed after 16 
hours. 
 
Virus generation and infection for RNA interference 
5 µg of lentiviral vector and 2,5 µg of each packaging vector 
(Ampho and Δ8.2) were cotransfected in 293T cells by calcium-
phosphate transfection. Supenatant was collected 36-48 hours after 
infection, filtered through a 0,45 µm filter and used directly to 
infect target cells. After 3 hours the supernatant was replaced with 
a fresh one. Two/three cycles of infections were repeated for two 
days. After 24 hours from the last cycle of infection, infected cells 
were selected with puromycin. An adapted protocol was followed 
to knock down PML in SK-LU-1 cells: at the end of selection (4 
days long) cells were submitted again to three cycles of infections, 
repeated for two days, and puromycin was added newly until the 
end of the experiment. 
 
Induction of dominant negative of TRF2 in HTC75 cells  
To induce the dominant negative of TRF2 in HTC75 cell line, 
doxycyclin was removed completely from the medium. 
 
 
 
 
RHPS4 treatment  
RHPS4 was synthesized as described previously. The drug, used at 
a concentration of 1 µM for 24 hours, was added to the cells 24 
hours after plating. 
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Growth curves 
After selection of PML knock down cells with puromycin, 3x103 
tumour cells, or 15x103 primary fibroblasts were seeded in a 6 
well plate, in triplicate. Cells were counted at 3, 6, 8 and 10 days 
after plating. Every experiment was repeated at least three times. 
 
Colony formation assay 
Five hundreds cells were seeded in triplicate on a 6 cm dish. Fresh 
medium was replaced after a week. Two weeks after the plating, 
colonies number and size were evaluated. 
For colonies number, cells were washed twice with PBS, fixed in 
5% formaldehyde, rinsed with water and stained for 5 minutes with 
0,05% crystal violet. Visible colonies were counted. 
Alternatively the number of colonies was counted at the 
microscope, than cells were collected and counted. The mean 
number of cells per colony was calculated dividing the number of 
cells on the plate for the total number of colonies, and represents a 
measure of the colonies size. 
The percentage of colonies or cells/colony was calculated respect 
the control considered as 100%. All experiments were repeated at 
least three times. Mean and s.d. were calculated among the 
experiments. 
 
β-Gal-staining 
Cells plated in 6 well dishes were washed in PBS, fixed 10 minutes 
at room temperature with 4% paraformaldehyde, washed and 
incubated over night at 37°C with a staining solution containing 1 
mg/ml of 5-bromo-4-chloro-3-indolyl β-D- galactoside (X-Gal), 5 
mM potassium ferrocyanide, 5mM potassium ferricyanide in a 
saline solution composed of 40 mM citric acid, 150 mM NaCl2, 2 
mM MgCl2 and sodium phosphate pH 6,0. Solution was removed 
from dishes that were washed 4- 6 times with PBS and cells were 
analyzed at the microscope. 
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Protein analysis  
 
Immunofluorescence 
Cells were cultured on coverslips, fixed in 4% paraformaldehyde 
for 10 minutes at room temperature. The fixed cells were washed 
twice in PBS, permeabilized in 0,1% Triton X-100 for 10 minutes 
and blocked for 1 hour in blocking buffer (PBS containing 2% 
BSA). After blocking, cells were incubated in primary antibody 
diluted in blocking buffer for 1 h at room temperature. Cells were 
then washed with PBS and incubated with fluorescent secondary 
antibody in blocking buffer for 45 min at room temperature. After 
incubation, cells were washed with PBS and their nuclei were 
stained with 4’,6-diamidino-2-phenylindole (DAPI). Slide were 
mounted and viewed with a x60 objective on a Olympus BX61 
wide-field microscope or a Leika TCSSP2 AOBS confocal 
microscope. Images were acquired with a CCD camera 
(Hamamatsu B/W CCD Camera CJ895). For quantification, 
multiple random fields were captured with the wide-field 
microscope and 50-100 cells were counted. 
The commercial primary antibodies used in this study were as 
follows: anti-PML (H238) (Santa Cruz, sc-5621), anti-γH2AX 
(Ser139) (Upstate 05-636), anti-TRF2 (clone 4A794, Millipore, 
05-521), anti-Histone H3 (tri methyl K9) (Abcam, ab8898), anti-
DNA-PKcs phosphorylated (Thr2609) (Biologend, 612901). 
The secondary antibodies were: CY5 donkey anti-Rabbit (Jackson 
Antibodies), 488 donkey anti-mouse (Alexa), 488 donkey anti-
rabbit (Alexa). 
 
Telomere Fluorescence in situ hybridization (T-FISH) 
Interphasic cells were grown on coverslips, fixed in 4% 
paraformaldehyde for 30 minutes at room temperature. The fixed 
cells were washed twice in PBS, treated with 100 mM glycine for 
20 min at room temperature to inactivate paraformaldehyde, and 
permeabilized in 0,5% Triton X-100/0,5% saponin for 1 h. After 
two washes in PBS, cells were blocked for 1 hour in blocking 
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buffer (PBS containing 2% BSA). After blocking, cells were 
incubated in primary and secondary antibodies as described above 
for immunofluorescence. Cells were then washed with PBS and 
treated newly with 4% paraformaldehyde for 30 minutes and 100 
mM glycine for 30 min. Then, Telomere-FISH was carried out 
using the Telomere PNA FISH Kit/Cy3 (DAKO, Glostrup, 
Denmark), accordingly to the protocol indicated. Briefly, 
coverslips were immersed in Tris-buffered Saline (TBS) two times 
for 5 min, and permeabilized with the pretreatment solution 
containing proteinase K. After washes with TBS, DNA was 
denatured by heat for 5 min at 80°C in the presence of ten micro 
liters of Cy3-conjugated telomere specific peptide nucleic acid 
(PNA) probe in hybridization solution containing 70% formamide. 
After hybridizing in the dark for 1 hour, slides were briefly 
immersed in Rinse Solution (supplied with the kit) and then 
washed twice at 46°C for 5 min in Wash Solution (supplied with 
the kit). After rinsing with TBS, slides were counter- stained with 
DAPI, and mounted with antifade solution (VectaShield, Vector 
laboratories Inc., Burlingame, CA, USA). 
 
Western blotting 
For immunoblotting, cells were lysated in SDS Laemmli Buffer, 
sonicated, boiled, separated by SDS-PAGE and transferred to 
nitrocellulose membranes, which were then blocked with 5% 
milk/TBS-T and incubated with primary specific antibodies. 
Horseradish peroxidase (HRP)-conjugated goat anti-rabbit or goat 
anti- mouse IgG (Amersham Bioscience) were used as secondary 
antibodies, and immunoblots were developed using the ECL 
reagent (Amersham Bioscience). The commercial antibodies used 
were: anti-PML (H238) (Santa Cruz, sc-5621), anti-TRF2 (clone 
4A794, Millipore, 05-521), anti-p53 (DO-1) (Santa Cruz, sc-126), 
anti-p21 (C-19) (Santa Cruz, sc-397), anti-p16 (H-156) (Santa 
Cruz, sc-759), anti- p15 (C-20) (Santa Cruz, sc-612), anti-p14 ARF 
(C-15) (Santa Cruz, sc-30547), anti-Phospho-Rb (Ser780) (Cell 
Signaling, 9307), anti-DNA-PKcs (Serotec, AHP318). 
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Immunoprecipitation 
For nuclear extracts preparation, cells were resuspended in E1A 
buffer (250 mM NaCl, 50 mM Hepes pH7.0, 0,1% NP40, 5 mM 
EDTA, 1 mM DTT, 50 µg/ml PMSF, 1 µg/ml leupeptin, 1 µg/ml 
aprotinin, 1 µg/ml pepstatin A, 0,2 mM sodium orthovanadate, 50 
mM sodium fluorure, 25 mM β-glycerophosphate, 10 mM 
niacinamide) and kept 15 minutes on ice. The lysates were 
centrifuged at 3000 rpm for 6 minutes. The supernatant, 
corresponding to the cytosol was discarded. The nuclear pellets 
were resuspended in E1A buffer, sonicated three times then 
centrifuged at 13200 rpm for 15 minutes at 4°C. Nuclear extacts 
were then pre- cleared with 30 µl Protein-A conjugated beads. 
Anti-DNA-PKcs (Serotec, AHP318), anti-PML (H238) (Santa 
Cruz, sc-5621) or anti-DNA-PKcs phosphorylated (Thr2609) 
(Biologend, 612901) were added to supernatants for 16 h at 4°C. 
Samples were incubated with Protein-A conjugated beads for 1 h at 
4°C and the beads were then washed six times with the E1A 
buffer. The immunoprecipitated proteins bounds to the beads were 
dissolved in SDS Laemmli Buffer, boiled, separated by SDS-
PAGE and blotted with the indicated antibodies. 50 µg of nuclear 
extracts were loaded as control (inputs). 
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Plasmids 
For RNA interference, pSicoR lentiviral vector was used232. 
Oligos coding for the various shRNAs were annealed and cloned 
into HpaI-XhoI digested pSicoR. Oligo design was as 
described241. The following oligonucleotides were chosen: 
 
PML KD1  
for:  
T-(GACCTCAGCTCTTGCATCA)-(TTCAAGAGA)- 
(TGATGCAAGAGCTGAGGTC)-TTTTTTC  
 
rev: TCGAGAAAAAA-(GACCTCAGCTCTTGCATCA)-
(TCTCTTGAA)-(TGATGCAAGAGCTGAGGTC)- A 
 
PML KD2 
for:  
T-(GGGACCCTATTGACGTTGA)-(TTCAAGAGA)-
(TCAACGTCAATAGGGTCCC)-TTTTTTC  
 
rev: 
TCGAGAAAAAA-(GGGACCCTATTGACGTTGA)-
(TCTCTTGAA)-(TCAACGTCAATAGGGTCCC)- A 
 
pSicoR Luc  
for:  
T-(CTTACGCTGAGTACTTCGA)-(TTCAAGAGA)- 
(TCGAAGTACTCAGCGTAAG)-TTTTTTC  
 
rev: TCGAGAAAAAA-(CTTACGCTGAGTACTTCGA)- 
(TCTCTTGAA)-( TCGAAGTACTCAGCGTAAG)- A 
 
TRF2 KD1 for: 
T-(GAGGATGAACTGTTTCAAG)-(TTCAAGAGA)- 
(CTTGAAACAGTTCATCCTC)-TTTTTTC  
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rev:  
TCGAGAAAAAA-(GAGGATGAACTGTTTCAAG)- 
(TCTCTTGAA)-(CTTGAAACAGTTCATCCTC)-A 
 
TRF2 KD2 
for:  
T-(GAACAGCTGTGATGATTAA)-TTCAAGAGA-
(TTAATCATCACAGCTGTTC)-TTTTTTC  
 
Rev 
TCGAGAAAAAA-(GAACAGCTGTGATGATTAA)-
(TCTCTTGAA)-(TTAATCATCACAGCTGTTC)-A 
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